Malignant neoplasm of rectum, including Hilmo

C3_RECTUM_WIDE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — C20 Hospital discharge: ICD-9 — 154 Hospital discharge: ICD-8 — 1541 Cause of death: ICD-10 — C20 Cause of death: ICD-9 — 154 Cause of death: ICD-8 — 1541 Cause of death: excluded ICD-9 — 1540\|154[2-3] Cancer registry: Topography ICD-O-3 — C20 Cancer registry: Morphology ICD-O-3 — ANY Cancer registry: Behaviour codes — 3 3 out of 7 registries used, show all original rules.	5901
4. Check minimum number of events None	5901
5. Include endpoints None	5901
6. Filter based on genotype QC (FinnGen only)	5313

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze: DF12

NAME	C3_RECTUM_WIDE
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	C20
HD_ICD_9	154
HD_ICD_8	1541
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C20
COD_ICD_9	154
COD_ICD_8	1541
COD_ICD_10_EXCL
COD_ICD_9_EXCL	1540\|154[2-3]
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C20
CANC_TOPO_EXCL
CANC_MORPH	ANY
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of rectum, including Hilmo based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Malignant neoplasm of rectum

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	5313	2080	3233
Unadjusted period prevalence (%)	1.19	0.74	1.48
Median age at first event (years)	68.17	66.43	69.29

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5482: Matched controls
54808

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

13.4

319.5

306

240

116

Kela drug reimbursment

Prostate cancer

+∞

313.6

298

JFF11

NOMESCO Finland

Laparoscopic loop enterostomy

408.9

312.3

311

JGB04

NOMESCO Finland

Laparoscopic partial proctectomy with partial excision of mesorectum

799.8

310.5

303

WF004

NOMESCO Finland

Palliative radiotherapy

3013.8

309.0

296

ZX090

NOMESCO Finland

Other technic of radiotherapy

360.3

308.7

309

B01AB05

ATC

enoxaparin; parenteral

5.2

307.7

3063

10758

Z51.5

ICD-10 Finland

Palliative care

9.3

307.7

1010

1305

SPAT1125

SPAT

Stoma care and guidance

13.0

307.7

397

327

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

307.7

641

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

47.9

307.7

282

WF049

NOMESCO Finland

Radiotherapy of metastasis

926.5

307.7

428

WX600

NOMESCO Finland

Single shot through catheter

68.3

307.7

509

WX402

NOMESCO Finland

General anaesthesia

4.5

307.7

1881

5687

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

396.6

307.7

632

C20

ICD-10 Finland

Malignant neoplasm of rectum

16384.0

307.7

1442

L02AE02

ATC

leuprorelin; implant, parenteral

51.8

307.7

200

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

307.7

477

JN3AD

NOMESCO Finland

Abdominal CT examination

4.2

307.7

1283

3733

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

3143.7

307.7

586

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

17.6

307.7

787

516

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

170.5

307.7

260

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

2095.5

307.7

410

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

11.4

307.7

366

342

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

307.7

564

TPH07

NOMESCO Finland

Cathetrisation of artery

5.3

307.7

1420

3402

WZC00

NOMESCO Finland

Treatment plan or consultation

4.2

307.7

2664

10068

JGB30

NOMESCO Finland

Abdominoperineal excision of rectum

1443.9

307.7

401

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

307.7

466

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

307.7

1166

XX3DW

NOMESCO Finland

Time consuming IT work

13.3

307.7

1211

1147

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

3850.8

307.7

698

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

723.5

307.7

584

JFF23

NOMESCO Finland

Transversostomy

234.5

307.7

1106

TJF80

NOMESCO Finland

Ostomy education

143.6

307.7

767

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

28.4

307.7

975

414

UJG02

NOMESCO Finland

Proctoscopy

19.4

307.7

716

422

ZXC96

NOMESCO Finland

Robot assisted procedure

45.9

307.7

345

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

18.9

307.7

1499

1068

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

307.7

4437

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

8.7

307.7

821

1087

A79

ICPC

Malignancy NOS

171.1

307.7

198

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

12400.5

307.7

2684

WF002

NOMESCO Finland

Radical radiotherapy

160.8

307.7

589

C61

ICD-10 Finland

Malignant neoplasm of prostate

477.5

307.7

519

JGB10

NOMESCO Finland

Partial proctectomy and end colostomy

176.9

307.7

188

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

307.7

926

WX408

NOMESCO Finland

General anesthesy, balanced

3.9

307.7

2093

7449

JN4AD

NOMESCO Finland

Body CT examination

13.4

307.7

1765

1872

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

224.6

307.7

979

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

+∞

307.7

313

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

9256.2

307.7

804

JFG20

NOMESCO Finland

Closure of enterostomy with resection of exteriorised loop

120.3

307.7

360

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

103.8

307.7

341

JGB03

NOMESCO Finland

Partial proctectomy with partial excision of mesorectum

1195.2

307.7

337

130

Kela drug reimbursment

Malignant tumour

+∞

307.7

2817

A03FA01

ATC

metoclopramide; systemic, rectal

15.8

307.7

2779

3356

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

9.1

307.7

577

696

JG1CG

NOMESCO Finland

Extensive MRI of rectum

471.0

307.7

699

Z43.3

ICD-10 Finland

Attention to colostomy

146.1

307.7

170

D75

ICPC

Malignant neoplasm colon/rectum

594.6

307.7

723

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

307.7

590

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

852.3

307.7

608

H02AB02

ATC

dexamethasone; systemic

84.2

307.7

1604

268

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

8702.7

307.7

763

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

346.7

307.7

504

JN4CD

NOMESCO Finland

Very extensive body CT

16.9

307.7

472

303

A04AA02

ATC

granisetron; systemic, transdermal

1245.0

307.7

1323

JGB07

NOMESCO Finland

Laparoscopic partial proctectomy with total excision of mesorectum

1474.2

307.7

533

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

172.2

307.7

458

A04AA01

ATC

ondansetron; systemic, rectal

15.3

307.7

783

592

L01BC06

ATC

capecitabine; oral

+∞

307.7

2301

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

307.7

3812

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

23.8

307.7

2625

2036

Z93.3

ICD-10 Finland

Colostomy status

128.1

307.7

655

JG1BG

NOMESCO Finland

MRI of rectum

746.4

307.7

878

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

99.3

307.7

762

TPX10

NOMESCO Finland

Implantation of vascular injection port

11.4

307.7

435

412

JFG40

NOMESCO Finland

Revision of enterostomy or colostomy without laparotomy

81.4

307.7

219

WX302

NOMESCO Finland

Thoracal epidural anesthesy

50.7

307.7

1750

502

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

3494.5

307.7

339

JFF10

NOMESCO Finland

Loop enterostomy

102.1

307.7

281

L03AA02

ATC

filgrastim; parenteral

125.6

307.7

194

B01AB10

ATC

tinzaparin; parenteral

5.5

307.7

1091

2359

JN4BD

NOMESCO Finland

Extensive body CT

18.4

307.7

1644

1248

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

5.5

307.7

730

1499

WZC30

NOMESCO Finland

Teaching

5.0

307.7

1554

4018

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

3677.3

307.7

671

UJF32

NOMESCO Finland

Coloscopy

9.3

307.7

3644

9597

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

1501.2

307.7

883

N02AA05

ATC

oxycodone; systemic

4.2

307.7

1693

5288

ZX070

NOMESCO Finland

Intensity modified radiotherapy

791.4

307.3

300

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

2958.4

303.7

291

ZXE20

NOMESCO Finland

More than three and less than five hours

3.6

303.1

1193

3887

A04AA55

ATC

palonosetron, combinations; systemic

+∞

300.8

286

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

300.8

286

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

10.1

285.5

331

346

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

284.9

271

JGB31

NOMESCO Finland

Laparoscopic and perineal excision of rectum

959.6

281.6

274

WW500

NOMESCO Finland

Blood transfusion

8.6

264.3

347

426

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

339.0

259.8

261

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

255.2

243

L01BC59

ATC

trifluridine, combinations; systemic

+∞

253.1

241

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.7

251.6

631

1471

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

4.2

247.6

744

1993

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

244.6

233

JF2AB

NOMESCO Finland

Colongraphy with X-ray

56.2

242.7

137

ZX120

NOMESCO Finland

Intravenous

4.1

240.3

731

1974

WX306

NOMESCO Finland

Lumbar epidural anesthesy

5.7

237.4

464

870

WF003

NOMESCO Finland

Adjuvant radiotherapy

488.4

237.1

235

D99

ICPC

Disease digestive system other

14.1

237.0

219

161

QBE15

NOMESCO Finland

Excision of other superficial lesion of skin of trunk

34.8

231.2

146

D18

ICPC

Change in faeces/bowel movements

6.8

230.8

373

579

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

10.0

229.9

267

279

K91.4

ICD-10 Finland

Colostomy and enterostomy malfunction

43.5

228.3

136

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

226.6

216

C209, 8148, 2

ICD-O-3

73.4

226.1

122

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

225.6

215

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.7

224.6

812

2469

L02BG04

ATC

letrozole; oral

35.3

224.0

141

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

34.4

222.5

141

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

747.6

220.5

216

JAH00

NOMESCO Finland

Laparotomy

7.1

217.4

338

503

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

15.3

216.6

191

129

115

Kela drug reimbursment

Breast cancer

+∞

216.1

206

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

44.1

210.4

125

JN2CM

NOMESCO Finland

Lower part of abdomen extensive MRI examination with Tesla magnet

80.9

208.6

111

L03AA13

ATC

pegfilgrastim; parenteral

700.7

206.8

203

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

15.0

206.2

184

127

8263/2-C20.9

ICD-O-3

Adenocarcinoma in situ in tubulovillous adenoma of rectum, NOS

61.2

205.1

114

JFB00

NOMESCO Finland

Partial resection of small intestine

9.8

203.7

239

253

PJA12

NOMESCO Finland

Sentinel node biopsy

689.9

203.7

200

R4110

NOMESCO Finland

Physiotherapy

2.5

203.7

1880

9517

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

4.8

203.4

486

1084

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

20.7

201.2

153

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

1894.8

200.1

193

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

6.1

199.3

361

628

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.3

199.0

855

2891

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

11.2

196.3

210

195

JGB37

NOMESCO Finland

Laparoscopic wide excision of rectum

+∞

194.9

186

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

190.7

182

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

24.5

188.9

134

A04AD12

ATC

aprepitant; systemic

950.3

188.7

184

TPH04

NOMESCO Finland

Cathetrisation of vein

2.5

187.2

1548

7400

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

32.8

185.3

119

ZZR00

NOMESCO Finland

Flap of skin

15.9

184.2

159

103

TQW40

NOMESCO Finland

Remowal of suture of skin

3.9

180.5

589

1660

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

5.3

175.0

365

723

WZC15, ,

NOMESCO Finland

47.2

174.4

102

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

18.4

172.1

138

ZX080

NOMESCO Finland

Image guided radiotherapy

1732.6

167.5

162

K56.7

ICD-10 Finland

Ileus, unspecified

7.2

167.1

254

368

ZXE30

NOMESCO Finland

More than five and less than seven hours

4.5

163.4

425

1011

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

35.0

163.3

103

Z51.0

ICD-10 Finland

Radiotherapy session

817.0

162.5

159

Z93

ICD-10 Finland

Artificial opening status

191.3

160.7

167

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

+∞

159.1

152

JGA73

NOMESCO Finland

Transanal excision of lesion of rectum

25.5

157.5

110

369

Kela drug reimbursment

Regorafenib

+∞

154.9

148

JGB36

NOMESCO Finland

Wide excision of rectum

1580.1

154.9

150

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

39.8

154.3

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

152.8

146

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

1555.0

152.8

148

8480/3-C20.9

ICD-O-3

Mucinous adenocarcinoma of rectum, NOS

+∞

150.7

144

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

146.5

140

C21.0

ICD-10 Finland

Malignant neoplasm: Anus, unspecified

+∞

146.5

140

Z93.2

ICD-10 Finland

Ileostomy status

23.2

145.2

105

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

144.4

138

176

Kela drug reimbursment

Regorafenib

+∞

143.3

137

JFB30

NOMESCO Finland

Right hemicolectomy

13.4

139.2

132

101

K45.8

ICD-10 Finland

Other specified abdominal hernia without obstruction or gangrene

14.1

139.1

128

D70.82

ICD-10 Finland

Drug-induced neutropenia

20.2

136.9

105

JN2DG

NOMESCO Finland

Very extensive MRI examination of lower part of abdoment with high intensity magnet

22.9

136.1

L02BA01

ATC

tamoxifen; oral

57.7

131.6

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

17.1

131.5

109

Y77

ICPC

Malignant neoplasm prostate

156.1

129.9

137

C21.1

ICD-10 Finland

Malignant neoplasm: Anal canal

+∞

129.7

124

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.6

129.4

854

3603

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

6.0

129.1

235

409

JN2BD

NOMESCO Finland

Extensive CT exmaniation of lower part of abdomen

38.1

128.2

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

127.6

122

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

6.6

126.0

206

322

A06AH03

ATC

naloxegol; oral

13.4

124.7

118

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

62.6

122.6

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

4.9

122.3

277

587

SPAT1262

SPAT

Handing over of treatment supplies

2.2

122.3

1299

6753

NK6AN

NOMESCO Finland

Total body bone isotope imaging

26.6

122.2

HAB40

NOMESCO Finland

Wedge excision of mammary gland

15.3

122.2

107

B01AB04

ATC

dalteparin; parenteral

3.7

121.5

410

1174

8240/3-C20.9

ICD-O-3

Neuroendocrine tumor, NOS, of rectum, NOS

+∞

121.3

116

YL1CD

NOMESCO Finland

Very extensive CT examination of pelvis for dose design of radiotherapy

+∞

121.3

116

XX2RW, ,

NOMESCO Finland

11.4

121.2

127

114

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

23.2

120.4

JFF26

NOMESCO Finland

Sigmoidostomy

47.2

119.6

R4190

NOMESCO Finland

Nutritional therapy

5.2

118.3

250

499

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.9

117.5

270

579

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

6.1

117.1

207

350

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

395.8

117.0

117

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

5.3

116.4

242

476

JG1DG

NOMESCO Finland

Very extensive MRI of rectum

392.3

116.0

116

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

4.0

113.9

345

916

JJB10

NOMESCO Finland

Atypcal resection of liver

+∞

112.9

108

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

3.5

112.3

404

1206

JAH01

NOMESCO Finland

Laparoscopy

4.5

111.7

284

661

ZXE10

NOMESCO Finland

More than one and less than three hours

1.9

110.9

2017

12678

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

110.8

106

JGB01

NOMESCO Finland

Laparoscopic partial proctectomy and colorectal or coloanal anastomosis

374.8

110.8

111

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

548.7

109.2

108

JH1CG

NOMESCO Finland

Extensive MRI of perianal area

19.2

108.4

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

4.2

106.9

295

731

C21.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of rectum, anus and anal canal

+∞

106.6

102

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

106.6

102

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

38.7

105.8

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

1037.9

104.6

102

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

20.5

103.9

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

5.3

102.2

209

405

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

46.6

102.1

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

20.3

102.0

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

3.8

101.2

322

884

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

16.6

101.2

L02BB03

ATC

bicalutamide; oral

+∞

100.3

JFF24

NOMESCO Finland

Laparoscopic transversostomy

260.1

100.1

102

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

975.6

98.3

1541A

ICD-9 Finland

Malignant neoplasm of rectum, rectosigmoid junction and anus, Rectum[NEOPLASMA MALIG RECTI,INVASIIVINEN KARSINOOMA]

+∞

98.2

JWA00

NOMESCO Finland

Repair of wound dehiscence in gastroenterological surgery

11.8

98.1

100

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

+∞

97.2

JGB20

NOMESCO Finland

Partial rectosigmoidectomy and abdominoperineal pull-through anastomosis

+∞

97.2

JN2BG

NOMESCO Finland

MRI examination of lower part of abdoment with high intensity magnet

19.2

97.1

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

3.7

96.7

323

916

C209, 8211, 2

ICD-O-3

39.7

96.7

Z43.2

ICD-10 Finland

Attention to ileostomy

117.8

96.3

104

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

12.8

95.7

HAC20

NOMESCO Finland

Total mastectomy

169.7

95.5

100

N03AX16

ATC

[U] pregabalin

2.0

94.4

1384

8006

JFF27

NOMESCO Finland

Laparoscopic sigmoidostomy

145.5

94.4

100

1XC07, ,

NOMESCO Finland

+∞

94.0

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

94.0

N02BE01

ATC

paracetamol; systemic, rectal

2.4

94.0

4882

42169

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

923.8

93.1

JWF00

NOMESCO Finland

Reoperation for insufficiency of anastomosis or suture in gastroenterological surgery

27.7

92.9

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

6.6

92.2

150

233

Z31.5

ICD-10 Finland

Genetic counselling

4.4

91.9

236

553

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.2

91.0

966

4958

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

7.0

90.9

140

205

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.9

90.6

463

1698

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

191.2

90.5

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

6.9

90.5

140

206

C18.90

ICD-10 Finland

Malignant tumor in unspecified location in the colon without histology

892.8

90.0

JFB60

NOMESCO Finland

Resection of sigmoid colon with end colostomy

12.6

88.9

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

+∞

88.8

XX1AD

NOMESCO Finland

Other CT-examination

157.6

88.3

K43.2

ICD-10 Finland

Incisional hernia without obstruction or gangrene

11.1

87.6

D16

ICPC

Rectal bleeding

4.3

87.6

229

544

JN2DM

NOMESCO Finland

Lower part of abdomen very extensive MRI examination with Tesla magnet

41.1

87.6

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

439.6

87.4

JG1CM

NOMESCO Finland

Extensive MRI of rectum (more than 1.5 T)

434.4

86.3

ZX121

NOMESCO Finland

Central venous catheter

34.1

84.9

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

45.9

84.7

WX704

NOMESCO Finland

Intubation

2.6

84.7

517

2078

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

6.7

83.9

134

204

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

413.7

82.2

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

10.9

80.9

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

3.3

80.0

324

1038

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

79.9

2769

20493

TJG20

NOMESCO Finland

Transanal irrigation

24.6

79.1

KCD02

NOMESCO Finland

Transurethral resection of bladder

10.1

78.8

JGA85

NOMESCO Finland

Endoscopic mucosal or submucosal resection in rectum

23.0

78.5

E0000UV, ,

ATC

1.7

78.2

2195

15309

ZX050

NOMESCO Finland

Stereotactic radiotherapy

35.3

77.7

Z3231

NOMESCO Finland

Registered nurse

1.8

77.7

1498

9375

TPX15

NOMESCO Finland

Removal of vascular injection port

22.1

77.3

K92.1

ICD-10 Finland

Melaena

2.7

77.0

448

1755

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

13.5

76.7

KC1GB

NOMESCO Finland

Cystography with X-ray

27.6

76.5

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

+∞

75.2

KBJ10

NOMESCO Finland

Cutaneous ureteroenterostomy

257.1

74.6

C50.99

ICD-10 Finland

Breast, unspecified

257.1

74.6

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

74.1

L01BC53

ATC

tegafur, combinations; systemic

+∞

73.1

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

37.8

72.7

XJG12

NOMESCO Finland

Transrectal endoscopic ultrasonography

23.8

72.6

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

72.0

D17

ICPC

Incontinence of bowel

5.8

70.6

129

225

JAG41

NOMESCO Finland

Repair of stomal hernia, laparoscopic

243.1

70.5

JFG30

NOMESCO Finland

Closure of colostomy with resection of exteriorised loop

30.9

70.2

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

4.4

70.1

179

417

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

5.4

70.1

141

269

K43.5

ICD-10 Finland

Parastomal hernia without obstruction or gangrene

97.6

70.0

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

97.6

70.0

JGB11

NOMESCO Finland

Laparoscopic partial proctectomy and end colostomy

+∞

69.9

UJF30

NOMESCO Finland

Ileoscopy through colon

2.2

69.8

646

3118

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

5.6

69.4

132

239

WGA11

NOMESCO Finland

Planning of pain management

11.2

69.2

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

686.8

69.2

JFF30

NOMESCO Finland

Other colostomy

36.1

68.6

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

6.6

68.3

110

169

Z85.0

ICD-10 Finland

Personal history of malignant neoplasm of digestive organs

17.9

68.0

L01EX05

ATC

regorafenib; oral

+∞

67.8

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

6.2

67.7

116

190

N82.3

ICD-10 Finland

Fistula of vagina to large intestine

31.7

67.6

OAB50, ,

SPAT

2.3

67.4

585

2748

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

232.8

67.4

HA1AA

NOMESCO Finland

X-ray mammography

3.8

67.3

214

586

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

+∞

66.8

KCC10

NOMESCO Finland

Cystoprostatectomy

+∞

66.8

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

66.8

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

3.6

66.4

229

662

JJB50

NOMESCO Finland

Excision of segments V, VI, VII and VIII of liver

172.1

65.1

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

64.7

L01XE21

ATC

[U] regorafenib

+∞

63.7

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

63.7

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

4.2

63.5

171

415

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.3

63.4

499

2247

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

62.8

1533

10155

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

62.6

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

62.6

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

+∞

62.6

R50.9

ICD-10 Finland

Fever, unspecified

2.0

62.0

798

4347

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

4.6

62.0

147

323

ZXE40

NOMESCO Finland

More than seven and less than nine hours

4.2

61.4

168

413

D28

ICPC

Limited function/disability (D)

13.3

61.3

JHA00

NOMESCO Finland

Anal or perianal incision

5.8

61.2

113

199

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

3.6

61.1

205

582

JFA58

NOMESCO Finland

Endoscopic dilatation of colon

17.4

60.9

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

60.4

1115

6813

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

84.8

60.0

G04BE03

ATC

sildenafil; oral

8.2

59.8

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

205.5

59.2

ZZR10

NOMESCO Finland

Flap of skin and muscle

15.6

58.8

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

15.0

58.8

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

2.7

58.3

325

1242

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

23.5

58.2

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

58.0

1926

13747

J01MA12

ATC

levofloxacin; systemic

1.8

57.6

1040

6304

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

57.4

A02BC02

ATC

pantoprazole; systemic

1.6

57.2

3621

30008

P01AB01

ATC

metronidazole; oral, rectal

1.6

57.2

1928

13799

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.2

56.9

505

2388

KBH20

NOMESCO Finland

Replantation of ureter

25.2

56.9

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

4.7

56.8

134

293

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

56.3

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

56.3

D77

ICPC

Malignant digestive neopl other/NOS

119.3

54.9

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

9.3

54.8

T81.9

ICD-10 Finland

Unspecified complication of procedure

4.4

54.7

140

327

V03AF03

ATC

calcium folinate; systemic

543.3

54.6

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

3.2

54.5

224

723

JFB20

NOMESCO Finland

Ileocaecal resection

11.3

54.4

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

54.2

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

54.2

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

11.5

54.2

D12.9

ICD-10 Finland

Benign neoplasm: Anus and anal canal

6.5

53.5

135

KH1YT

NOMESCO Finland

Percutaneous implantation of endoprothesis with radiological guidance

21.2

53.2

JEA00

NOMESCO Finland

Appendectomy

2.6

53.1

313

1230

6434

FHL

Anterior resection

85.3

53.0

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.5

52.9

358

1503

UKC02

NOMESCO Finland

Cystoscopy

1.8

52.7

963

5843

WX110

NOMESCO Finland

Infiltration anesthesia

1.6

52.7

3410

28122

8000/3-C20.9

ICD-O-3

Neoplasm, malignant of rectum, NOS

+∞

52.2

JHA10

NOMESCO Finland

Biopsy of anal canal

20.1

52.1

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

10.7

51.5

S18

ICPC

Laceration/cut

1.5

51.4

2499

19312

JN2AD

NOMESCO Finland

CT examination of lower part of abdomen

12.2

51.3

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

263.0

51.2

C18.91

ICD-10 Finland

Malignant tumor of unspecified location in colon invasive carcinoma

+∞

51.1

JFB43

NOMESCO Finland

Left hemicolectomy

10.7

50.6

KA3EB

NOMESCO Finland

Antegrade pyelography

12.0

50.5

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

4.5

50.1

123

278

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

50.1

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

50.1

S77

ICPC

Malignant neoplasm of skin

18.3

49.9

JWW96

NOMESCO Finland

Other reoperation in gastroenterological surgery

18.3

49.9

UJF34

NOMESCO Finland

Left colonoscopy

7.2

49.9

104

JJB71

NOMESCO Finland

Laparoscopic resection of liver

492.2

49.5

JFA70

NOMESCO Finland

Suture of small intestine

12.7

49.4

C18.9

ICD-10 Finland

Malignant neoplasm: Colon, unspecified

+∞

49.0

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

48.0

K61.1

ICD-10 Finland

Rectal abscess

12.1

47.9

JJB30

NOMESCO Finland

Excision of two segments of liver

168.1

47.9

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

6.4

47.7

125

J01MA02

ATC

ciprofloxacin; systemic

1.5

47.3

2097

15797

ZXD05

NOMESCO Finland

Urgent procedure

1.6

46.6

1546

10908

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.8

46.6

827

4958

JFB46

NOMESCO Finland

Resection of sigmoid colon

5.5

46.5

166

XJA00

NOMESCO Finland

Intraoperative abdominal ultrasonography

461.6

46.3

128

Kela drug reimbursment

Cancers of female genital organs

461.6

46.3

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

46.1

662

3718

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

45.9

8070/3-C20.9

ICD-O-3

Squamous cell carcinoma, NOS, of rectum, NOS

+∞

45.9

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

45.9

C209, ,

ICD-10 Finland

+∞

45.9

6435

FHL

Abdominoperineal resection and colostomy

161.4

45.9

UJH02

NOMESCO Finland

Anoscopy

2.7

45.4

256

983

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

16.6

45.3

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

44.8

ZXE00

NOMESCO Finland

One hour or less

1.5

44.8

1837

13567

YX9AW, ,

NOMESCO Finland

441.2

44.3

D29

ICPC

Digestive symptom/complaint other

3.4

44.1

162

488

JG001

NOMESCO Finland

Preopertaive radiotherapy of rectum

+∞

43.8

178

Kela drug reimbursment

Combination product containing tegafur, gimeracil and oteracil

+∞

43.8

JAL30

NOMESCO Finland

Omentectomy

10.5

43.7

ZX112

NOMESCO Finland

Subcutaneous

6.1

43.5

127

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

13.3

43.4

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

4.5

43.3

107

243

JFK10

NOMESCO Finland

Freeing of adhesions in intestinal obstruction

9.5

43.3

D01.2

ICD-10 Finland

Carcinoma in situ: Rectum

221.7

43.0

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

151.2

42.8

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

42.8

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

42.8

Z71.8

ICD-10 Finland

Other specified counselling

1.5

42.4

1612

11680

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

4.8

42.0

201

LEC00

NOMESCO Finland

Partial excision of vagina

79.1

41.9

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

6.0

41.9

125

WB111

NOMESCO Finland

Multiple neoadjuvant cytostatic therapy

+∞

41.7

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.4

41.6

286

1208

Y83.2

ICD-10 Finland

Surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

9.5

41.5

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.1

41.5

401

1955

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

211.5

40.9

C50

ICD-10 Finland

Malignant neoplasm of breast

211.5

40.9

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

40.7

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

+∞

40.7

N02AX02

ATC

tramadol; systemic, rectal

1.5

40.5

2211

17218

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

400.4

40.1

JFF13

NOMESCO Finland

Terminal enterostomy

13.2

39.9

PJD44

NOMESCO Finland

Excision of iliac lymph nodes

141.0

39.8

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

39.6

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

39.6

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

39.5

1679

12416

SPAT1109

SPAT

Analgesia with portable analgesic pump

9.1

39.5

JJB60

NOMESCO Finland

Other excsion of three or more segments of liver

390.2

39.1

JFB50

NOMESCO Finland

Other resection of colon

13.3

39.1

JN6AD

NOMESCO Finland

CT of torso and neck

6.2

39.0

110

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

4.7

38.7

191

JJB20

NOMESCO Finland

Excision of single segment of liver

+∞

38.6

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

38.6

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

3.3

38.3

148

460

K59.09

ICD-10 Finland

Constipation, unspecified

2.0

38.3

438

2272

JGA05

NOMESCO Finland

Endoscopic polypectomy in rectum

5.8

38.1

123

JJ6LT

NOMESCO Finland

Coagulation of focal hepatic lesion under ultrasound guidance

380.0

38.1

WX725

NOMESCO Finland

Noninvasive ventilation

2.3

38.0

309

1404

XJW99

NOMESCO Finland

Other investigative procedure on digestive system

11.2

38.0

WPB10

NOMESCO Finland

Making a convalescent care decision

11.9

37.6

L02BX02

ATC

degarelix; parenteral

+∞

37.5

C77.5

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes

+∞

37.5

JN3GE

NOMESCO Finland

Intraoperative ultrasound examination of abdomen

369.8

37.0

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

5.4

36.8

134

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

4.9

36.7

168

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.1

36.6

154

504

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

36.5

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

+∞

36.5

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

36.5

JKA20

NOMESCO Finland

Cholecystectomy

2.8

36.3

183

663

D40.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Prostate

4.6

36.1

190

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

7.4

36.0

XKD00

NOMESCO Finland

Uroflowmetry

1.6

35.9

909

5964

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

35.9

850

5485

SPAT1153

SPAT

Removal of sutures

1.5

35.8

1566

11602

L02AE04

ATC

triptorelin; parenteral

186.2

35.8

X76

ICPC

Malignant neoplasm breast female

127.5

35.7

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

11.7

35.1

L02BG03

ATC

anastrozole; oral

124.1

34.7

K62.1

ICD-10 Finland

Rectal polyp

4.0

34.7

247

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

34.7

776

4931

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

5.2

34.5

135

15411

ICD-8 Finland

Malignant neoplasm of rectum and rectosigmoid junction, Rectum

+∞

34.4

C18

ICD-10 Finland

Malignant neoplasm of colon

+∞

34.4

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

34.4

A06AD11

ATC

lactulose; oral

1.6

34.1

866

5678

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

42.3

34.0

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

3.7

33.8

106

288

K43.3

ICD-10 Finland

Parastomal hernia with obstruction, without gangrene

120.8

33.7

JAD10

NOMESCO Finland

Repair of incisional hernia

5.3

33.6

127

JFK00

NOMESCO Finland

Division of adhesive band in intestinal obstruction

10.1

33.6

ZXC40

NOMESCO Finland

Use of ultrasound

8.5

33.5

WB101

NOMESCO Finland

Simple cytostatic neoadjuvant therapy

+∞

33.4

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

33.4

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

+∞

33.4

KA1AE

NOMESCO Finland

Kidney ultrasound examination

3.0

33.2

147

496

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

329.1

32.9

WVA20

NOMESCO Finland

Medicine administration

2.8

32.5

162

584

JA3CT

NOMESCO Finland

Cathetrisation of abdominal cavity with CT guidance

37.5

32.4

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

32.4

383

2007

K62.7

ICD-10 Finland

Radiation proctitis

+∞

32.3

JG1BM

NOMESCO Finland

MRI of rectum (more than 1.5 T)

+∞

32.3

WX892

NOMESCO Finland

Monitored bed care

1.9

31.9

431

2362

LCD00

NOMESCO Finland

Hysterectomy

2.6

31.9

186

727

WX610

NOMESCO Finland

Patient controlled analgesia

7.6

31.8

UJF32, ,

SPAT

2.5

31.8

211

877

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

5.7

31.7

105

L02AE03

ATC

goserelin; implant

9.5

31.5

GDB21

NOMESCO Finland

Thoracoscopic segmental resection of lung

36.6

31.5

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.3

31.4

118

361

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

2.4

31.3

224

963

JFA55

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in colon

7.2

31.3

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

31.3

8070/3-C21.1

ICD-O-3

Squamous cell carcinoma, NOS, of anal canal

+∞

31.3

JFB54

NOMESCO Finland

Laparoscopic resection of sigmoid colon with partial proctectomy

42.5

30.8

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

7.2

30.5

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

30.2

R33

ICD-10 Finland

Retention of urine

1.7

30.1

540

3226

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

41.3

29.9

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.4

29.8

206

872

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

155.8

29.7

JGA98

NOMESCO Finland

Other transluminal endoscopic local operation on rectum

45.2

29.6

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

3.9

29.6

226

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

+∞

29.2

8210/3-C20.9

ICD-O-3

Adenocarcinoma in adenomatous polyp of rectum, NOS

+∞

29.2

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

29.2

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

29.2

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

+∞

29.2

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

29.2

XX1XW

NOMESCO Finland

Extensive written report from radiologist

3.2

29.2

119

383

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

4.2

29.2

189

JAG43

NOMESCO Finland

Repair of stomal hernia with mesh

57.0

29.1

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

57.0

29.1

WPA13

NOMESCO Finland

Palliative consultation

8.3

29.1

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.9

29.0

354

1875

Z3226

NOMESCO Finland

Physiotherapist

1.6

29.0

849

5740

KBV00

NOMESCO Finland

Insertion of stent into ureter

5.7

28.9

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

66.3

28.9

KA1FN

NOMESCO Finland

Isotope renography

6.8

28.8

ZYC01

NOMESCO Finland

Remote contact by phone

2.1

28.8

293

1455

WX002

NOMESCO Finland

Sedation and analgesia

1.5

28.8

954

6630

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

4.9

28.5

127

JGA75

NOMESCO Finland

Endoscopic microsurgical excision of lesion of rectum

48.8

28.4

XJH00

NOMESCO Finland

Transanal ultrasonography

2.0

28.3

343

1811

YX9CD

NOMESCO Finland

Other very extensive CT eamination for dose design of radiotherapy

+∞

28.1

1541X

ICD-9 Finland

Malignant neoplasm of rectum, rectosigmoid junction and anus, Rectum[NEOPLASMA MALIG RECTI,EI HISTOLOGISTA VAHVISTUSTA]

+∞

28.1

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

+∞

28.1

G04CA02

ATC

tamsulosin; oral

1.4

28.1

1620

12524

JFA42

NOMESCO Finland

Endoscopic injection in colon

6.4

28.1

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

100.6

27.7

K83.1

ICD-10 Finland

Obstruction of bile duct

4.5

27.5

147

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.7

27.2

596

3754

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.9

27.2

385

2141

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

27.1

L02BB04

ATC

enzalutamide; oral

+∞

27.1

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

+∞

27.1

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

27.1

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.7

27.0

593

3735

R15

ICD-10 Finland

Faecal incontinence

2.5

26.5

171

702

R19.4

ICD-10 Finland

Change in bowel habit

2.4

26.4

178

745

ZXE60

NOMESCO Finland

More than 12 and less than 15 hours

4.8

26.4

124

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.2

26.2

102

319

1XC08, ,

NOMESCO Finland

+∞

26.1

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

26.1

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

3.5

26.0

252

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

8.9

25.9

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.1

25.6

257

1269

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.2

25.4

209

955

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

4.2

25.2

162

TKC20

NOMESCO Finland

Catheterisation of bladder

1.8

25.0

384

2188

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

25.0

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

25.0

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

25.0

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

25.0

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

25.0

KBV10

NOMESCO Finland

Removal of stent from ureter

4.9

25.0

114

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

39.0

24.8

L02BG06

ATC

exemestane; oral

251.3

24.7

LEE10

NOMESCO Finland

Repair of vagina using graft or flap

251.3

24.7

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

251.3

24.7

Z2221

NOMESCO Finland

Medical doctor

1.4

24.6

1179

8781

JHW96

NOMESCO Finland

Other operation on anus or perianal tissue

6.6

24.6

NET99

NOMESCO Finland

Other operation on pelvis

130.6

24.6

JFB47

NOMESCO Finland

Laparoscopic resection of sigmoid colon

4.0

24.4

170

JAL20

NOMESCO Finland

Excision or destruction of lesion of peritoneum

24.4

24.3

WX882

NOMESCO Finland

High dependency care

2.5

24.3

157

645

TQW99

NOMESCO Finland

Other minor procedure on skin

2.3

24.3

190

850

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.1

24.3

244

1206

JFB53

NOMESCO Finland

Resection of sigmoid colon with partial proctectomy

48.5

24.3

R11

ICD-10 Finland

Nausea and vomiting

1.8

24.2

394

2283

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

24.0

8140/3-C18.4

ICD-O-3

Adenocarcinoma, NOS, of transverse colon

+∞

24.0

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

24.0

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

+∞

24.0

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

24.0

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

24.0

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.2

23.9

193

875

JJB40

NOMESCO Finland

Excision of segments II, III and IV of liver

241.0

23.7

G62.0

ICD-10 Finland

Drug-induced polyneuropathy

23.7

23.4

D12.7

ICD-10 Finland

Benign neoplasm: Rectosigmoid junction

3.6

23.4

212

JAG00

NOMESCO Finland

Repair of other hernia

21.4

23.4

GDB10

NOMESCO Finland

Wedge resection of lung

28.3

23.1

WPA44, ,

SPAT

8.4

23.1

K56.0

ICD-10 Finland

Paralytic ileus

3.5

23.1

233

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

36.4

23.0

C18.60

ICD-10 Finland

Malignant tumor of the descending colon without histology

+∞

22.9

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

+∞

22.9

C18.40

ICD-10 Finland

Malignant tumor of the transverse colon without histology

+∞

22.9

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

22.9

384

Kela drug reimbursment

Combination product containing tegafur, gimeracil and oteracil

+∞

22.9

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

22.9

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

22.9

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

22.9

Z2446

NOMESCO Finland

Social worker

2.0

22.7

260

1346

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

230.9

22.6

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

26.0

22.6

Z93.8

ICD-10 Finland

Other artificial opening status

120.5

22.6

HAB99

NOMESCO Finland

Other partial excision of mammary gland

5.1

22.5

DHB00

NOMESCO Finland

Excision of lesion of external nose

7.8

22.5

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

7.2

22.4

K43.0

ICD-10 Finland

Incisional hernia with obstruction, without gangrene

3.8

22.2

173

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.8

22.2

351

2018

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.1

21.9

201

959

K63.5

ICD-10 Finland

Polyp of colon

2.4

21.9

146

609

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

+∞

21.9

L01AX03

ATC

temozolomide; systemic

+∞

21.9

8070/3-C21.0

ICD-O-3

Squamous cell carcinoma, NOS, of anus, NOS

+∞

21.9

8010/3-C20.9

ICD-O-3

Carcinoma, NOS, of rectum, NOS

+∞

21.9

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

21.9

8144/3-C20.9

ICD-O-3

Adenocarcinoma, intestinal type of rectum, NOS

+∞

21.9

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

62.7

21.8

UKB02

NOMESCO Finland

Retrograde ureteroscopy

3.9

21.7

167

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

80.4

21.7

GD1AD

NOMESCO Finland

Thorax CT examination

1.9

21.5

300

1658

R03AC02

ATC

salbutamol; inhalant

0.7

21.5

1794

21614

N02BF02

ATC

pregabalin; oral

1.8

21.5

325

1842

KH1AA

NOMESCO Finland

Urinary tract X-ray examination without contrast

3.2

21.5

264

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

31.3

21.4

GDC00

NOMESCO Finland

Lobectomy of lung

23.2

21.2

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

21.2

708

4903

A28

ICPC

Limited function/disability NOS

1.4

21.2

1054

7879

KCD32

NOMESCO Finland

Cystoscopic destruction of tumour of bladder

5.5

21.0

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1755

3686

6.53

307.65

2.3

2.0

0.21

0.20

g/l

11.73

1701

3357

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2561

10202

3.83

307.65

3.5

2.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3900

19496

4.47

307.65

4.2

2.5

—

estimate

—

(3044640) Blood type and Crossmatch panel - Blood

3079

13374

3.97

307.65

3.7

2.2

—

(4035726) Immunohistochemistry procedure

1269

1179

13.70

307.65

1.4

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

593

535

12.30

307.65

5.4

2.0

56.16

26.33

u/ml

3.07

535

489

(3032080) INR in Blood by Coagulation assay

3950

23462

3.44

307.65

13.1

19.4

1.20

1.36

inr

73.34

3216

19728

(3022145) Colonoscopy Study observation

2565

4759

9.25

307.65

1.7

1.3

—

(40768804) Tissue Pathology biopsy report

2860

13666

3.28

307.65

2.8

1.7

—

(3033658) Prothrombin time (PT) actual/Normal

2392

10926

3.11

307.65

5.5

3.8

88.83

84.66

14.40

2372

10678

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1449

4038

4.52

307.65

2.2

2.3

32.87

51.18

u/l

0.87

1304

3368

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

4200

2449

70.04

307.65

9.9

1.4

35.03

14.37

ug/l

0.85

3827

1847

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1275

911

17.93

307.65

6.1

1.9

464.51

182.87

u/ml

0.42

1177

732

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4218

22934

4.64

307.65

15.1

4.0

11.20

12.38

umol/l

6.34

4158

21570

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1732

4774

4.84

307.65

2.6

2.2

7.44

8.18

umol/l

0.66

1598

4146

(3002256) Pathology report gross observation

1350

3490

4.80

307.65

1.3

1.1

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

3971

20717

4.32

307.65

10.7

4.1

33.60

35.46

g/l

75.71

3877

19113

(3013650) Neutrophils [#/volume] in Blood by Automated count

3780

23954

2.86

279.13

17.4

6.4

3.95

4.40

e9/l

26.59

3294

20295

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

936

2818

3.80

265.09

9.1

10.6

16.03

16.10

0.35

917

2726

(3023368) Bacteria identified in Blood by Culture

2558

13650

2.64

262.00

5.4

4.1

—

(3003694) ABO and Rh group [Type] in Blood

2163

10904

2.62

245.30

1.4

1.3

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1250

4980

2.96

220.99

8.5

8.6

117.38

122.85

g/l

20.22

1229

4871

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2601

14876

2.42

218.11

2.7

2.4

56.78

61.58

u/l

4.13

2513

13667

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2516

14314

2.40

211.77

4.1

2.7

31.26

35.38

u/l

1.95

2442

13345

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4600

34594

3.05

207.06

17.2

5.9

89.15

76.92

u/l

35.18

4515

32289

(3016502) Oxygen saturation in Arterial blood

1289

5473

2.77

200.15

8.2

8.0

97.12

94.98

30.80

1253

5286

(3019977) pH of Arterial blood

1376

6079

2.69

197.28

8.1

7.8

7.41

7.42

4.08

593

3521

(3014111) Lactate [Moles/volume] in Serum or Plasma

1126

4527

2.87

193.31

7.2

7.8

1.19

1.41

mmol/l

9.58

1109

4432

(3027801) Oxygen [Partial pressure] in Arterial blood

1367

6093

2.66

191.89

8.1

7.7

14.91

11.49

kpa

78.55

1333

5856

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1367

6098

2.65

191.53

8.1

7.7

5.19

5.04

kpa

9.06

1335

5873

(3014007) Fractional oxyhemoglobin in Arterial blood

920

3323

3.12

191.27

8.7

10.1

95.57

93.40

26.16

920

3307

(3003396) Base excess in Arterial blood by calculation

1355

6033

2.65

190.46

8.1

7.7

0.52

1.11

mmol/l

6.91

1211

4940

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

882

3215

3.08

179.77

8.9

10.3

0.60

0.65

3.86

877

3196

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

897

3352

3.00

174.65

8.8

9.9

1.24

1.36

3.15

892

3332

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

825

2964

3.10

171.98

8.7

10.0

23.94

24.29

mmol/l

2.70

817

2887

(3015377) Calcium [Moles/volume] in Serum or Plasma

2499

15141

2.19

170.00

8.3

2.2

2.35

mmol/l

0.54

2356

13312

(3000991) Gas panel - Venous blood

1047

4317

2.76

169.38

8.0

9.1

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

3882

28108

2.30

167.08

6.6

5.0

6.99

6.89

mmol/l

2.46

3792

26727

(3037121) Protein [Mass/volume] in Urine

543

1537

3.81

164.88

6.1

2.7

212.71

520.18

mg/l

1.59

420

585

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1483

7357

2.39

161.94

5.8

2.6

0.79

0.82

mmol/l

26.42

1426

6790

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3452

24191

2.15

155.94

9.0

6.5

1.19

1.21

mmol/l

50.28

3052

20725

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3157

21619

2.08

148.51

8.2

6.2

1.19

1.21

mmol/l

39.69

2980

19624

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1705

9368

2.19

142.96

8.6

2.2

2.48

2.45

mmol/l

28.13

1599

8267

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

524

1609

3.49

140.17

2.5

3.2

0.29

0.34

iu/ml

2.98

241

932

(3030467) Casts [#/volume] in Urine by Automated count

2197

13433

2.06

137.89

3.8

3.2

0.51

0.46

e6/l

0.35

1662

9875

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

813

3328

2.69

130.96

1.6

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

2602

17200

1.98

128.22

3.9

3.4

—

1.40

—

(3002582) Erythrocytes [#/volume] in Urine

2425

15671

1.98

127.38

4.0

3.3

66.70

77.42

e6/l

0.24

1888

11985

(36304419) Bacteria [Presence] in Urine

2055

12577

2.01

125.77

3.7

3.1

0.33

180.79

estimate

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1375

7521

2.10

112.28

3.6

3.0

2.59

2.21

e6/l

0.56

718

3729

(3031040) Bacteria [#/volume] in Urine by Automated count

3850

29853

1.97

110.36

5.4

4.8

1020.06

2138.20

e6/l

0.90

473

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1417

7936

2.06

107.97

2.3

2.8

2.34

2.28

g/l

3.13

1341

7242

(3022948) Iron [Moles/volume] in Serum or Plasma

1487

8478

2.03

107.84

2.5

2.8

11.34

12.59

umol/l

7.91

1417

7789

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1328

7302

2.08

106.11

2.3

2.8

19.65

22.22

9.59

1268

6702

(3018095) Leukocytes [#/volume] in Urine

2542

17449

1.85

104.42

4.8

3.9

170.93

117.84

e6/l

1.58

1928

12377

(3042936) Bacteria identified in Isolate by Culture

1224

6646

2.08

100.47

2.3

2.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1414

8429

1.91

87.15

3.5

2.9

1.01

1.15

e6/l

0.72

760

4651

(3026008) Bacteria identified in Urine by Culture

2106

14266

1.77

85.20

3.8

3.4

—

(42870588) Differential panel, method unspecified - Blood

2151

14836

1.74

80.43

4.7

5.5

—

(3026782) Osmolality of Urine

1474

9099

1.85

80.40

3.6

2.9

517.92

535.10

mosm/kgh2o

2.55

1336

7882

(40758558) Short blood count panel - Blood

1943

13059

1.76

79.37

12.6

4.7

—

(40768800) Prostate Pathology biopsy report

150

292

5.25

72.90

1.2

—

(3006504) Eosinophils/Leukocytes in Blood

2724

20412

1.66

72.14

5.2

5.8

2.69

2.98

8.25

2551

18826

(3019069) Monocytes/Leukocytes in Blood

2728

20468

1.66

71.74

5.3

5.9

9.24

9.11

1.24

2556

18881

(3022096) Basophils/Leukocytes in Blood

2725

20470

1.66

71.08

5.3

5.9

0.58

0.67

13.66

2552

18882

(3002030) Lymphocytes/Leukocytes in Blood

2762

20843

1.65

70.57

5.3

5.8

22.85

26.56

50.49

2604

19478

(3020779) Urea [Moles/volume] in Serum or Plasma

857

4660

1.99

67.34

5.2

7.3

9.55

11.31

mmol/l

9.03

832

4414

(3018010) Neutrophils/Leukocytes in Blood

2703

20465

1.63

66.73

5.1

5.8

61.00

58.18

24.14

2577

19325

(3000850) Epithelial cells [#/volume] in Urine

1643

10974

1.71

65.93

3.0

2.7

4.92

4.51

e6/l

0.55

1522

9926

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1866

12944

1.67

64.64

2.4

3.17

2.81

mg/l

5.75

1614

11122

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

13.29

57.05

1.3

1.0

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

287

1041

2.85

56.87

3.5

1.5

38.44

27.50

u/ml

1.01

279

990

(3018418) pH of Serum or Plasma

1967

14218

1.60

55.63

5.1

3.6

7.40

0.42

1324

10125

(3001604) Monocytes [#/volume] in Blood

2851

22504

1.56

54.41

5.1

5.6

0.62

e9/l

0.01

2347

19035

(3006315) Basophils [#/volume] in Blood

2859

22609

1.55

53.90

5.1

5.6

0.04

e9/l

12.54

2360

19142

(3019198) Lymphocytes [#/volume] in Blood

2893

23003

1.54

52.73

5.2

5.7

1.63

1.82

e9/l

3.74

2456

19918

(3013115) Eosinophils [#/volume] in Blood

2911

23285

1.53

50.82

5.2

5.7

0.18

0.21

e9/l

10.62

2456

20011

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4817

43571

1.87

49.03

32.9

16.0

37.15

25.41

mg/l

103.18

4593

35872

(3048689) Calprotectin [Mass/mass] in Stool

847

5047

1.80

48.92

1.7

2.3

261.16

151.37

ug/g

7.85

664

3999

(3025941) Bacteria identified in Stool by Culture

441

2136

2.16

46.53

1.3

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

425

2031

2.18

46.39

2.0

1.8

2.46

1.71

ug/l

0.77

384

1767

(40768441) Liver Pathology biopsy report

149

5.78

46.31

1.1

1.4

—

(40768795) Lymph node Pathology biopsy report

8.51

45.90

1.3

1.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1269

8573

1.62

45.78

1.9

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

339

1520

2.31

43.12

1.3

1.2

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2510

19906

1.48

42.67

3.0

3.1

148.41

138.81

ug/l

0.54

2320

18321

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

784

4762

1.75

41.91

3.3

2.3

255.00

234.63

u/l

1.78

750

4398

(3039000) Anion gap in Blood by calculation

257

1032

2.56

41.64

8.6

6.8

10.91

11.45

mmol/l

2.37

234

930

(3018572) Chloride [Moles/volume] in Blood

257

1032

2.56

41.64

8.6

6.8

106.60

104.74

mmol/l

9.92

234

930

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

262

1064

2.54

41.47

2.0

2.3

3.73

3.64

g/l

0.38

255

1008

(3003458) Phosphate [Moles/volume] in Serum or Plasma

964

6272

1.65

39.74

4.8

5.9

1.02

1.04

mmol/l

0.99

914

5762

(3047181) Lactate [Moles/volume] in Blood

333

1534

2.25

39.68

7.5

5.8

1.36

1.33

mmol/l

0.21

295

1363

(3007930) Methemoglobin/Hemoglobin.total in Blood

441

2281

2.01

38.87

6.7

4.9

0.89

0.87

0.55

417

2164

(3021589) Normoblasts [#/volume] in Blood

2446

19615

1.45

37.50

18.9

10.7

0.00

e9/l

1.23

1954

15998

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

463

2485

1.94

36.63

6.4

4.7

1.55

1.60

0.77

438

2358

(3008152) Bicarbonate [Moles/volume] in Arterial blood

597

3476

1.80

36.58

8.2

6.8

24.50

24.49

mmol/l

0.03

575

3349

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

770

4848

1.68

35.70

5.0

3.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

162

560

2.95

35.03

1.2

1.3

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

547

3142

1.82

34.99

1.8

1.7

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1104

7654

1.55

34.30

2.0

1.9

29.77

29.89

0.29

1085

7442

(40768793) Breast Pathology biopsy report

217

4.10

32.10

1.4

1.2

—

(3045142) Bone marrow Pathology biopsy report

206

4.17

31.73

1.3

1.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

831

5485

1.61

31.67

1.8

1.9

—

(3019060) Gas panel - Arterial blood

550

3348

1.71

28.57

6.3

4.7

—

(3051651) Icteric interference index of Serum or Plasma

217

3.87

27.98

5.1

4.2

0.96

0.85

index

0.55

212

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

262

1273

2.11

27.25

1.3

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

267

1307

2.10

27.23

1.9

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

932

6523

1.52

27.01

1.8

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

4573

42238

1.50

26.22

34.8

15.7

77.50

74.91

ml/min/173m2

16.63

4384

39150

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

872

6086

1.51

25.47

1.8

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

218

3.71

25.46

1.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

+∞

23.97

1.0

0.0

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

216

1027

2.15

23.77

2.2

2.4

218.71

197.50

2.67

208

967

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

9.68

23.20

7.1

1.2

16.06

56.68

ug/l

1.53

(3012544) pH of Venous blood

804

5625

1.50

23.03

3.3

3.8

7.38

0.12

477

3294

(3049717) Cytology report of Urine Cyto stain

308

1683

1.88

22.93

2.6

1.8

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

3787

34131

1.35

22.52

3.8

4.5

16.45

12.53

mm/h

32.63

3512

31690

(3021447) Carbon dioxide [Partial pressure] in Venous blood

791

5545

1.50

22.39

3.3

3.7

5.73

5.82

kpa

1.84

771

5411

(3027945) Reticulocytes/Erythrocytes in Blood

847

6040

1.48

21.99

2.3

2.0

1.75

1.76

0.07

759

5270

(3002032) Base excess in Venous blood by calculation

771

5402

1.50

21.84

3.3

3.8

1.74

1.83

mmol/l

0.26

662

4744

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

568

3731

1.58

21.61

1.4

1.5

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

422

2586

1.68

21.22

1.5

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1610

19672

0.74

21.19

1.9

2.0

1.40

1.33

mmol/l

1.47

1297

16214

(3019550) Sodium [Moles/volume] in Serum or Plasma

4853

45781

1.52

21.09

39.8

20.3

139.26

139.80

mmol/l

43.25

4805

44827

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

+∞

20.84

1.1

0.0

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

4857

45862

1.52

20.63

40.0

20.4

3.95

4.01

mmol/l

43.71

4808

44838

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

557

8102

0.65

19.79

1.3

47.90

37.31

iu/ml

0.58

173

2470

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

519

7623

0.65

19.26

1.2

1.3

11.59

13.57

u/ml

0.26

193

2860

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3134

27838

1.29

18.62

3.8

3.2

63.31

49.82

u/l

7.84

2969

25639

(3036489) Thrombin time

268

1498

1.83

18.58

1.9

20.72

21.01

0.39

254

1325

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

147

666

2.24

18.31

5.8

6.4

12.39

12.26

mg/l

0.11

128

609

(3024522) Salmonella sp identified in Specimen by Organism specific culture

126

544

2.35

17.58

1.4

1.3

—

(3004809) Band form neutrophils/Leukocytes in Blood

123

530

2.35

17.25

2.8

2.3

3.16

1.23

3.42

113

449

(4281824) Cell count and differential, peritoneal fluid

216

3.17

17.18

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

109

446

2.47

17.13

4.6

3.7

10.17

12.98

index

2.35

213

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

416

2680

1.60

17.10

2.3

2.5

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

3828

35079

1.30

17.03

43.5

19.4

14.51

13.68

148.54

3806

34536

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

461

3052

1.56

16.84

3.0

4.0

24.06

24.21

mmol/l

0.40

456

3010

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

124

542

2.32

16.84

1.4

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

126

556

2.30

16.74

1.4

1.3

—

(3021601) Nitrite [Presence] in Urine by Test strip

2779

24532

1.27

16.35

4.7

4.0

0.00

estimate

0.80

675

4896

(40762365) Oxygen content in Arterial blood by calculation

5.18

16.24

4.5

2.6

13.81

15.16

ml/dl

1.72

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

538

3713

1.50

16.18

4.6

3.3

1.22

mmol/l

1.00

472

3104

(3025468) Yersinia sp identified in Specimen by Organism specific culture

118

514

2.32

16.17

1.4

1.3

—

(3023520) Reticulocytes [#/volume] in Blood

651

4673

1.45

16.01

2.4

2.1

66.82

68.07

e9/l

0.42

466

3482

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

117

517

2.29

15.52

1.4

1.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

226

2.99

15.33

2.4

1.6

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

117

520

2.28

15.32

1.4

1.3

—

(3009261) Glucose [Presence] in Urine by Test strip

2814

24988

1.26

15.31

4.8

4.0

0.00

0.02

estimate

1.41

661

4616

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

210

1160

1.84

15.16

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

211

1172

1.83

14.97

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

102

434

2.38

14.77

1.7

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

211

1179

1.82

14.69

1.2

—

(3018405) Lactate [Moles/volume] in Arterial blood

295

1812

1.66

14.69

4.5

4.1

1.34

1.43

mmol/l

0.51

286

1770

(3035350) Ketones [Presence] in Urine by Test strip

2796

24884

1.25

14.63

4.8

4.0

10.86

3.33

estimate

0.82

698

5045

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

302

1877

1.64

14.36

2.0

1.8

—

(40761536) Microorganisms panel - Urine sediment

476

3293

1.49

14.11

5.0

4.1

—

(3019225) pH of Specimen

638

4675

1.41

13.92

4.4

3.7

7.36

0.12

509

3112

(3052851) Hemolysis interference index of Serum or Plasma

219

1265

1.76

13.66

4.9

3.6

3.32

1.66

index

3.93

136

620

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4819

46051

1.38

13.30

21.4

11.1

24.15

25.70

u/l

10.50

4749

44318

(3012501) Base excess in Blood by calculation

179

985

1.84

13.13

4.4

4.3

2.62

2.65

mmol/l

0.06

131

645

(3024354) Oxygen [Partial pressure] in Venous blood

637

4721

1.39

12.97

2.9

3.1

4.48

4.47

kpa

0.02

618

4591

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

279

1751

1.62

12.79

2.0

1.7

—

(1616796) Gas panel - Central venous blood

193

1101

1.78

12.59

3.7

3.9

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4160

43873

0.78

12.50

4.9

5.7

4.49

4.45

mmol/l

1.28

3795

40754

(3017181) Myelocytes/Leukocytes in Blood

529

3825

1.42

12.40

3.4

3.7

1.10

0.69

3.10

196

814

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

175

976

1.82

12.32

1.6

1.5

—

(3002179) Metamyelocytes/Leukocytes in Blood

508

3662

1.43

12.11

3.3

3.6

0.79

0.54

2.02

192

804

(3021440) Promyelocytes/Leukocytes in Blood

512

3714

1.42

11.78

3.5

3.8

0.18

0.07

2.54

181

707

(3023183) Ammonium ion [Moles/volume] in Plasma

186

1072

1.76

11.74

2.2

2.5

36.43

33.90

umol/l

0.55

167

959

(3020564) Creatinine [Moles/volume] in Serum or Plasma

4871

46788

1.37

11.62

44.4

21.5

81.08

83.27

umol/l

3.56

4828

46099

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4135

43556

0.79

11.59

4.8

5.6

1.44

1.43

mmol/l

0.75

3751

40161

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

128

658

1.97

11.58

2.3

5.6

819.73

775.16

iu/ml

0.02

(3017143) Hepatitis C virus Ab [Presence] in Serum

475

3411

1.43

11.56

1.3

1.6

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

451

2.15

11.09

1.5

1.4

194.58

79.87

pmol/l

0.88

434

(3043410) Blood group antigens tested for on Red Blood Cells

116

3.38

11.06

2.6

1.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

181

1062

1.73

10.76

1.4

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3961

41817

0.81

10.56

4.2

4.7

1.29

mmol/l

0.11

3552

38125

(3025159) Blasts/Leukocytes in Blood

511

3776

1.39

10.54

3.5

3.9

0.36

0.04

0.53

177

693

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4104

43154

0.80

10.46

6.8

7.4

40.54

40.44

mmol/mol

0.23

3774

40105

(3021879) Hepatitis B virus core Ab [Presence] in Serum

315

2131

1.51

10.42

1.2

1.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

352

2454

1.46

10.04

1.7

1.6

1.71

1.55

g/l

2.46

309

2086

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

512

3821

1.37

9.94

4.3

2.5

62.82

62.69

ml/min/173m2

0.02

218

1542

(3017732) Neutrophils [#/volume] in Blood

709

5565

1.31

9.82

5.0

2.8

4.37

4.73

e9/l

1.50

628

4669

(3003327) Ova and parasites identified in Stool by Light microscopy

210

1321

1.61

9.61

1.6

1.7

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

+∞

9.37

1.0

0.0

—

(3037522) Nuclear Ab [Titer] in Serum

459

6100

0.73

9.32

1.3

520.00

514.90

titre

0.02

1346

(3014051) Protein [Presence] in Urine by Test strip

1461

12567

1.22

9.25

3.5

3.0

0.14

0.05

0.54

408

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

127

711

1.80

8.94

1.5

1.4

—

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

4879

47154

1.31

8.89

51.9

24.7

38.27

40.44

165.14

4836

46467

(3000963) Hemoglobin [Mass/volume] in Blood

4880

47165

1.31

8.89

51.0

24.4

126.63

136.06

g/l

303.61

4841

46510

(3035941) MCH [Entitic mass]

4879

47155

1.31

8.88

50.5

24.1

30.19

30.51

26.80

4837

46484

(3024731) MCV [Entitic mean volume] in Red Blood Cells

4879

47156

1.31

8.87

50.5

24.1

91.49

91.66

1.66

4838

46479

(3017354) Segmented neutrophils/Leukocytes in Blood

377

2.11

8.85

2.5

2.3

62.28

60.19

0.38

311

(3026361) Erythrocytes [#/volume] in Blood

4879

47159

1.31

8.84

50.6

24.2

4.26

4.49

e12/l

164.48

4783

45761

(3010813) Leukocytes [#/volume] in Blood

4879

47162

1.31

8.82

50.7

24.2

6.77

6.78

e9/l

0.15

4784

45752

(3007461) Platelets [#/volume] in Blood

4878

47152

1.31

8.81

50.7

24.2

247.41

239.81

e9/l

11.54

4798

45968

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1214

10300

1.23

8.71

3.6

4.4

679.00

533.87

ng/l

0.37

1019

8754

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3161

33875

0.84

8.70

3.8

4.1

15.05

14.97

pmol/l

1.09

2818

30687

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4290

44710

0.81

8.67

5.6

6.6

2.57

2.56

mmol/l

0.29

3890

41407

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

101

532

1.91

8.62

1.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

406

2987

1.39

8.60

3.1

3.5

2.16

1.86

mmol/l

0.76

292

2168

(3004119) Hemoglobin [Mass/volume] in Venous blood

470

3549

1.35

8.47

2.7

3.3

123.75

130.48

g/l

8.13

457

3447

(3004716) Salmonella sp identified in Stool by Organism specific culture

242

1624

1.51

8.37

1.2

1.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

167

2.65

8.26

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

167

2.65

8.26

1.4

—

(3015736) pH of Urine

2195

19762

1.18

8.25

4.0

3.6

6.18

6.25

2.00

1122

10706

(3000570) Elastase.pancreatic [Mass/mass] in Stool

210

1373

1.55

8.20

1.4

249.90

280.42

ug/g

1.24

127

849

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1969

17582

1.19

8.11

2.9

3.4

1419.67

1585.18

ng/l

1.23

1742

15312

(40768806) Pleura Pathology biopsy report

413

1.98

7.65

1.4

1.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1091

9266

1.22

7.64

1.2

1.3

1.22

1.85

u/ml

1.63

293

2417

(3009343) pH of Capillary blood

449

3426

1.34

7.55

3.2

3.6

7.42

0.14

374

2846

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

462

3540

1.33

7.55

3.2

3.6

5.08

5.16

kpa

1.13

433

3360

(3003434) Protein [Mass/volume] in Pleural fluid

110

623

1.78

7.52

1.4

1.5

30.89

28.42

g/l

1.17

547

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

171

1091

1.59

7.46

1.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

929

7791

1.23

7.33

1.5

1.4

2.62

2.69

g/l

0.43

529

4438

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

161

2.56

7.24

1.6

1.3

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

161

2.56

7.24

1.6

1.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

161

2.56

7.24

1.6

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

199

2.37

7.09

1.3

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

199

2.37

7.09

1.3

1.2

—

(40767503) Oxygen content in Capillary blood by calculation

162

1034

1.58

7.08

3.0

2.6

15.49

16.55

3.76

162

1012

(3021960) Folate [Moles/volume] in Serum or Plasma

1727

15388

1.18

7.06

1.8

1.7

19.79

20.08

nmol/l

0.34

1470

12877

(3012441) Differential panel - Pleural fluid

461

1.88

7.04

1.5

—

(3012516) Albumin [Mass/volume] in Urine

1680

18759

0.85

7.00

3.6

3.5

59.79

47.63

mg/l

1.65

1165

12263

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

291

2.11

6.93

1.3

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

298

2.09

6.91

1.3

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

7.52

6.88

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

161

2.49

6.74

1.6

1.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

262

1874

1.42

6.60

1.0

1.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

155

997

1.57

6.58

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

155

997

1.57

6.58

1.3

—

(3009508) Creatinine [Moles/volume] in Urine

1717

19068

0.85

6.56

3.5

7.41

7.46

mmol/l

0.19

1415

15986

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.96

6.52

1.3

1.1

—

(3028626) Oxygen [Partial pressure] in Capillary blood

188

1266

1.50

6.48

3.3

2.9

7.93

7.88

kpa

0.17

182

1233

(46235355) HIV 1 and 2 tests - Meaningful Use set

555

4457

1.27

6.40

1.4

1.6

—

(3035715) Granulocytes [#/volume] in Blood

111

662

1.69

6.39

3.5

3.3

4.11

4.34

e9/l

0.46

111

662

(3011397) Hemoglobin [Presence] in Urine by Test strip

1350

11869

1.18

6.36

3.6

3.9

0.29

0.18

0.25

156

(21494434) Karyotype in Bone marrow

235

2.18

6.35

1.2

1.1

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

536

4291

1.28

6.34

3.0

2.4

0.55

0.42

e6/l

0.90

523

4122

(3020682) Albumin/Creatinine [Ratio] in Urine

1729

19147

0.86

6.29

4.4

4.2

11.32

8.43

mg/mmol

0.92

1131

12134

(3024928) Oxygen saturation in Venous blood

199

1365

1.47

6.28

1.9

3.1

59.71

61.32

0.44

193

1310

(3027273) Bicarbonate [Moles/volume] in Venous blood

349

2643

1.34

6.21

3.4

3.3

24.76

25.21

mmol/l

1.30

333

2555

(3035933) Granulocytes/Leukocytes in Blood

124

772

1.62

6.06

3.9

3.1

59.51

58.89

0.18

124

772

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

406

1.86

6.02

1.3

1210.78

299.91

u/l

0.53

382

(3013512) EKG study

1993

18136

1.16

5.96

4.2

3.9

0.83

0.73

—

(1002224) Polysomnography panel

105

1694

0.61

5.88

1.1

—

(3000012) Reticulocyte production index

115

712

1.63

5.77

2.3

1.7

0.86

0.90

0.27

456

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

140

912

1.55

5.68

1.3

1.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

482

1.75

5.60

1.4

1.5

21683.33

65306.86

e6/l

1.48

273

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

12.87

5.57

1.0

—

(3022806) Fractional oxyhemoglobin in Capillary blood

565

1.69

5.57

1.9

1.8

89.24

89.48

0.14

558

(3001893) Eosinophils/Leukocytes in Pleural fluid

129

2.49

5.43

1.5

1.04

2.26

1.36

110

(3023199) Leukocytes [#/volume] in Pleural fluid

550

1.68

5.32

1.4

1.5

1067.71

2712.63

e6/l

2.10

397

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

125

2.49

5.27

6.5

1.1

56.64

93.97

u/ml

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

235

2.05

5.19

1.7

1.9

2.47

1.86

u/field

0.30

153

(3008757) Leukocyte morphology finding [Identifier] in Blood

328

1.87

5.06

3.1

2.7

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

110

2.55

5.03

1.6

1.4

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

3.28

5.02

3.1

1.1

1.37

3.01

ug/l

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

111

2.53

4.94

1.6

1.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

111

2.53

4.94

1.6

1.4

—

(3029937) Albumin [Presence] in Urine by Test strip

1556

14069

1.15

4.88

5.1

4.2

0.01

0.00

estimate

0.22

578

4447

(40760892) CBC W Ordered Manual Differential panel - Blood

1028

9018

1.17

4.84

4.5

4.3

—

(3002619) Bacteria identified in Specimen by Culture

101

2.58

4.79

1.2

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

6.48

4.76

1.1

1.2

1.00

1.08

u/field

—

(40765096) Chromosome analysis panel by Banding

3.41

4.74

1.3

1.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

103

2.53

4.62

3.3

2.4

1.21

1.13

0.11

103

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

145

998

1.46

4.60

1.3

1.4

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

305

3886

0.77

4.59

1.4

1.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1369

12316

1.15

4.57

4.9

3.5

0.01

0.17

estimate

1.02

521

3789

(3024891) Influenza virus A+B Ag [Presence] in Specimen

141

967

1.47

4.56

1.1

1.2

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2165

20070

1.13

4.56

4.0

4.2

56.28

82.38

ng/l

0.50

1766

15316

(3045788) Cell count panel - Pleural fluid

444

1.70

4.55

1.4

1.5

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

355

1.78

4.54

1.5

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

263

1.91

4.47

1.5

1.3

—

(4094501) Cardiovascular stress test using bicycle ergometer

1464

0.64

4.44

1.1

—

(3017569) Oxygen content in Arterial blood

336

1.79

4.42

2.4

1.9

15.44

16.23

1.18

336

(3045424) Erythrocytes [Presence] in Urine

302

2359

1.30

4.40

4.0

1.9

0.01

0.36

estimate

0.49

714

(1761482) Bacteria [#/volume] in Urine by Culture

178

1285

1.40

4.37

5.3

4.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

419

1.70

4.37

2.6

3.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

310

1.81

4.29

2.4

1.6

8.32

8.48

mmol/l

0.06

310

(3045414) Leukocytes [Presence] in Urine

572

4817

1.21

4.28

3.3

2.0

0.00

0.01

estimate

0.96

101

941

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

203

2705

0.74

4.25

1.2

1.3

85.54

56.85

au/ml

—

182

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

244

1861

1.33

4.24

3.0

3.9

24.79

24.86

mmol/l

0.10

216

1682

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

447

1.66

4.20

1.1

—

(4034850) Laboratory test

110

1624

0.67

4.19

12.7

10.5

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4232

43571

0.87

4.18

5.1

5.8

6.14

6.09

mmol/l

1.35

3832

39705

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

588

1.57

4.16

1.2

1.1

1.62

1.54

g/l

1.17

527

(3036782) Glucose [Moles/volume] in Pleural fluid

419

1.68

4.11

1.2

1.4

6.55

6.51

mmol/l

0.04

381

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

114

768

1.49

4.07

1.1

1.2

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

699

0.51

4.04

3.8

4.7

308.28

345.43

umol/l

0.87

599

(1761868) Lipid panel - Serum or Plasma

1372

15073

0.88

4.03

3.3

3.6

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

399

1.69

4.02

1.8

2.1

2.63

1.50

u/field

0.87

214

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

105

699

1.51

3.98

1.3

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

333

1.75

3.97

1.4

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

333

1.75

3.97

1.4

1.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

333

1.75

3.97

1.4

1.3

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

304

1.78

3.95

1.3

15.02

11.53

u/l

0.32

272

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

122

839

1.46

3.94

1.3

1.4

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1540

16775

0.89

3.92

2.2

2.3

210.43

246.83

u/l

0.79

1468

15752

(3036603) Volume of Urine

298

1.79

3.90

1.8

1.5

1907.77

1922.49

0.05

286

(3008898) HLA-B27 [Presence]

1094

0.62

3.89

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.89

3.89

1.9

2.2

156.71

4.90

ug/l

0.68

(3022313) Gas panel - Capillary blood

305

2427

1.27

3.87

3.1

3.7

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

175

1291

1.37

3.82

2.7

2.2

123.72

131.08

g/l

3.29

136

1010

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

230

2958

0.77

3.77

2.3

2.4

47.95

21.84

au/ml

0.85

220

(3026692) Albumin [Mass/volume] in Peritoneal fluid

127

2.21

3.75

1.4

1.8

11.28

13.21

g/l

0.69

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

252

1.83

3.70

1.5

1.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

387

1.66

3.66

1.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3992

41141

0.89

3.56

4.7

5.2

2.03

2.01

mu/l

0.37

3575

37593

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

360

2951

1.24

3.55

4.2

3.9

44.74

47.05

1.05

355

2910

(21494755) Public health laboratory ask at order entry panel

177

2339

0.75

3.55

1.3

1.4

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1243

0.66

3.46

1.3

1.7

4.53

5.02

mg/l

0.13

936

(3019832) Treponema pallidum Ab [Presence] in Serum

105

1502

0.69

3.45

1.3

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

290

1.73

3.36

1.5

1.3

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

121

860

1.42

3.34

1.3

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

154

2.02

3.34

1.5

1.4

56.70

62.99

0.34

127

(3011648) Oxygen content in Venous blood

532

1.53

3.33

1.3

2.2

10.88

10.66

0.18

532

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

109

2.21

3.24

1.3

694.71

4.62

ug/l

0.57

(3000330) Specific gravity of Urine by Test strip

323

2648

1.23

3.21

5.3

3.4

1.02

ratio

0.13

294

2409

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

171

2235

0.76

3.20

1.3

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

3.80

3.18

1.0

1.1

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1091

9902

1.13

3.07

1.7

2.07

1.27

mg/l

5.40

901

7742

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

126

1708

0.73

3.05

1.3

1.6

—

(3000494) Fungus identified in Specimen by Culture

633

5544

1.16

3.03

1.6

1.5

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

570

1.48

2.99

1.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

113

1553

0.72

2.99

1.2

1.6

—

(3035880) pH of Pleural fluid

243

1.73

2.89

1.2

1.3

7.46

7.43

0.92

164

(3005322) IgE [Units/volume] in Serum or Plasma

212

2655

0.79

2.87

1.2

1.3

213.48

248.56

u/ml

0.32

189

2467

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

162

1240

1.32

2.86

2.5

2.7

1.82

1.79

mg/l

0.19

146

1073

(3015171) Extractable nuclear Ab [Units/volume] in Serum

127

1700

0.74

2.85

1.2

4.31

0.68

u/ml

0.85

152

(3035320) C reactive protein [Mass/volume] in Body fluid

345

1.60

2.81

2.5

3.0

32.01

33.49

mg/l

0.10

256

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

842

0.64

2.80

1.1

1.2

0.68

0.63

ratio

0.59

145

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

2.47

2.78

1.6

1.4

26.00

8.21

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

945

0.66

2.73

1.2

1.54

1.51

g/l

0.39

945

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

137

1032

1.34

2.72

1.2

1.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

271

1.67

2.70

2.8

1.5

126.45

1687.50

u/l

0.93

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

160

1.88

2.70

1.4

2.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

429

0.51

2.63

1.1

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

236

1921

1.24

2.57

3.1

2.9

24.27

24.79

mmol/l

1.00

231

1889

(3023487) Leukocytes [#/volume] in Peritoneal fluid

149

1.88

2.55

2.0

2.6

738.44

635.14

e6/l

0.14

110

(3044007) Cell count panel - Peritoneal fluid

121

1.99

2.54

2.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

182

0.33

2.51

1.2

2.0

19.80

209.84

ug/l

—

170

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

136

1.92

2.49

2.6

30.43

43.18

2.62

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

247

2028

1.23

2.49

2.1

2.2

509.63

681.41

ug/l

0.57

240

1931

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

158

1.84

2.47

1.4

2.0

14.90

17.56

0.69

152

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

428

4931

0.86

2.46

1.4

—

(36660697) Celiac disease serology panel - Serum

384

3291

1.18

2.46

1.1

1.2

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

3.81

2.46

1.1

2.0

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

183

2282

0.79

2.44

1.8

3.56

3.44

mmol/l

0.67

125

1661

(3036481) Cortisol [Moles/volume] in Serum or Plasma

436

3783

1.17

2.40

2.0

1.8

416.98

371.02

nmol/l

3.87

412

3435

(3029396) Erythrocyte agglutination [Presence] in Blood

5.00

2.40

1.3

2.4

—

(1175426) CD3 cells/Lymphocytes in Blood

168

1.79

2.35

1.4

2.0

71.20

71.70

0.05

156

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1020

0.70

2.35

1.2

1.3

7.20

27.83

e6/l

1.84

763

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

2.26

2.33

2.6

1.9

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1215

0.73

2.33

1.2

1.3

3.32

5.22

u/ml

0.73

174

(3000475) Leukocytes [#/volume] in Synovial fluid

110

1454

0.75

2.33

1.5

1.6

9143.64

13932.85

e6/l

1.20

1036

(3040151) Glucose [Moles/volume] in Capillary blood

619

1.40

2.32

6.2

18.4

6.74

7.51

mmol/l

2.51

514

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

104

1384

0.75

2.31

1.6

0.67

2.64

iu/ml

0.43

285

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

561

6302

0.88

2.28

10.8

7.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

657

0.64

2.27

1.5

1.8

—

(3037756) Immunofixation for Serum or Plasma

129

992

1.31

2.27

1.6

1.2

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1036

0.71

2.27

1.3

1.4

3484.31

975.60

e6/l

0.48

832

(3047189) Immunofixation for 24 hour Urine

179

1.74

2.21

1.7

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

147

1854

0.79

2.19

1.7

6.15

6.79

iu/ml

0.10

449

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

272

1.59

2.19

2.0

2.1

58.89

223.88

ug/min

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

3.34

2.18

1.0

1.1

8.70

8.67

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

3.34

2.18

1.0

1.1

36.10

36.01

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

3.34

2.18

1.0

1.1

22.00

21.34

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2446

23411

1.08

2.16

2.3

2.2

88.05

94.42

pmol/l

9.23

1470

12346

(3000093) Morphology [Interpretation] in Blood Narrative

444

1.45

2.14

1.1

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

183

0.38

2.13

1.1

200.71

229.51

iu/ml

—

178

(3032773) Endomysium IgG Ab [Titer] in Serum

379

1.48

2.12

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

259

1.59

2.11

1.5

9.56

7.62

u/l

0.30

205

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

460

0.58

2.10

1.1

—

0.28

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

138

1084

1.28

2.10

1.6

1.7

—

(3007566) Smooth muscle Ab [Titer] in Serum

149

1184

1.27

2.07

1.2

122.50

126.40

titre

—

111

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

448

1.43

2.05

1.2

82.03

56.01

u/l

0.59

381

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

110

1.91

2.05

1.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

487

4317

1.14

2.03

2.6

1.6

65.16

66.53

g/l

3.25

445

3859

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

123

1568

0.78

2.03

1.3

1.4

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

684

0.67

2.00

1.4

1.6

63.61

59.77

0.24

446

(3026493) Urate [Moles/volume] in Serum or Plasma

1218

13027

0.92

1.98

2.7

2.6

359.26

360.37

umol/l

0.13

1049

11242

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

311

0.51

1.97

1.4

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

438

0.59

1.96

1.1

—

25.44

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1210

0.76

1.93

1.2

7.27

8.52

u/ml

—

112

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2225

21286

1.08

1.93

5.3

4.4

2.59

2.06

ug/l

2.77

1963

19246

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1011

0.74

1.88

1.2

1.3

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

529

4743

1.13

1.86

2.5

3.2

222.65

236.17

ng/l

0.30

484

4370

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

374

1.45

1.86

1.8

1.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

380

0.58

1.84

1.1

—

(3019150) Specific gravity of Urine by Refractometry

1067

11443

0.92

1.84

4.4

4.3

1.02

1.29

kg/l

0.81

782

7538

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

122

1.81

1.83

2.2

2.3

22820.67

28280.67

e6/l

0.07

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

4.17

1.82

1.4

1.6

0.24

5.73

mg/l

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

113

1432

0.78

1.81

1.4

1.9

40.12

44.05

nmol/l

1.55

106

1381

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.92

1.79

1.2

1.5

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

131

1.76

1.77

1.6

2.4

0.63

0.62

mmol/l

0.18

131

(3034770) Mitochondria Ab [Titer] in Serum

146

1185

1.24

1.74

1.2

280.00

1160.57

titre

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

544

0.66

1.73

1.3

1.7

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

170

1.65

1.73

3.2

2.6

4.83

5.07

kpa

0.55

170

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

170

1.65

1.73

3.2

2.6

10.02

10.13

kpa

0.08

170

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

192

0.47

1.72

1.1

830.78

1676.41

miu/ml

—

192

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.92

1.72

1.0

—

(3005719) IgG [Mass/volume] in Serum or Plasma

340

2982

1.15

1.70

2.9

2.3

9.94

10.89

g/l

4.20

315

2745

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

148

1.69

1.5

—

(3006245) CD3-CD19+ cells/cells in Blood

2.00

1.69

1.3

1.9

16.80

8.50

0.73

(3011544) Albumin [Mass/volume] in Pleural fluid

2.44

1.64

1.1

1.2

19.79

14.06

g/l

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

963

0.75

1.62

1.1

2.30

3.12

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

696

1.30

1.61

1.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2318

22324

1.07

1.57

2.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1927

18448

1.07

1.57

4.9

4.1

0.02

0.12

estimate

1.58

544

3975

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

191

2252

0.84

1.56

1.2

154.45

118.42

u/ml

0.51

842

(44790048) Parainfluenza type 2 nucleic acid detection

543

1.33

1.55

1.2

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

543

1.33

1.55

1.2

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

543

1.33

1.55

1.2

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

543

1.33

1.55

1.2

1.4

—

(4015189) Microbial culture of sputum

156

0.45

1.54

1.4

2.7

—

(3020876) Protein [Mass/time] in 24 hour Urine

631

1.30

1.54

2.4

2.1

0.73

1.33

g/24h

2.93

346

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.03

1.53

1.0

1.2

68.86

144.60

ng/l

—

(3020393) Adenovirus Ag [Presence] in Stool

2.43

1.53

1.1

1.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

383

0.62

1.52

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

270

0.55

1.50

1.3

2.1

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

0.00

1.49

0.0

1.1

—

76.99

—

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

1.90

1.49

1.3

1.9

34.53

26.18

0.93

(3003329) Lymphocytes/Leukocytes in Synovial fluid

512

0.68

1.48

1.4

1.6

35.87

29.84

0.35

337

(3010144) Erythrocytes [#/volume] in Synovial fluid

547

0.69

1.47

1.3

1.4

77985.55

186290.36

e6/l

1.00

376

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

166

0.48

1.46

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

166

0.48

1.46

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

166

0.48

1.46

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

166

0.48

1.46

1.0

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

330

0.60

1.46

1.2

1.4

200.03

197.44

pmol/l

0.03

330

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.50

1.45

1.0

1.1

—

(4212803) Bone marrow aspirate examination

2.50

1.45

1.0

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

403

1.37

1.44

1.8

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

353

1.39

1.43

1.1

1.2

—

(3026051) Granulocytes/Leukocytes in Pleural fluid

1.79

1.42

1.4

14.55

29.17

1.41

(3022493) Free Hemoglobin [Mass/volume] in Plasma

221

1.50

1.40

1.1

5.9

48.39

84.96

mg/l

1.97

145

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

225

0.53

1.39

1.1

1.0

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

180

0.50

1.38

1.2

1.1

—

9.37

u/ml

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

300

0.60

1.38

1.9

1.8

282.15

342.43

mu/l

0.53

223

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

119

1.68

1.37

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

120

0.42

1.37

3.2

6.6

7.90

8.87

mmol/l

—

120

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.94

1.36

1.4

1.2

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

0.00

1.34

0.0

1.5

—

0.85

—

(3024263) Appearance of Synovial fluid

271

0.59

1.32

1.1

1.6

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.50

1.30

1.5

1.6

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

116

955

1.22

1.28

1.0

1.1

1.39

10.27

eliau/ml

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.78

1.28

1.0

1.1

189.20

241.22

nmol/l

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

147

1737

0.84

1.28

1.6

1.5

0.36

0.33

mg/l

0.22

801

(3028717) Thiamine [Mass/volume] in Blood

1.94

1.27

1.0

1.1

61.50

67.81

ug/l

0.62

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

135

0.44

1.26

1.2

1.1

—

(3034092) Cytoplasmic Ig cells/cells in Blood

2.05

1.26

18.0

10.3

0.23

0.22

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

186

1602

1.17

1.25

3.1

1.5

3.41

1.58

ratio

0.66

101

920

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

107

1.68

1.25

2.5

2.2

7.58

8.00

mmol/l

0.14

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

195

1.49

1.23

1.5

2.1

91.62

96.35

0.32

184

(3003740) Influenza virus B Ag [Presence] in Specimen

459

1.31

1.23

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

116

1393

0.83

1.22

2.7

2.2

166.55

117.44

ug/min

0.38

818

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

601

1.27

1.22

1.0

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

2.63

1.21

6.8

6.9

10.40

8.42

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

2.63

1.21

3.4

3.5

31.20

45.32

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

288

3222

0.89

1.20

2.0

2.2

3.48

3.49

ratio

0.04

232

2621

(3042631) Mycobacterium sp identified in Specimen

612

1.26

1.19

1.9

3.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

419

1.32

1.17

1.0

1.1

3.05

3.14

eliau/ml

0.02

158

(3004616) Nuclear Ab [Presence] in Serum

577

0.74

1.15

1.1

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

606

1.26

1.15

1.3

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

1.14

0.0

1.2

—

(21494814) CD8 cells/Lymphocytes in Specimen

1.71

1.11

1.5

2.2

31.07

24.90

0.70

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

192

1.46

1.11

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

312

1.35

1.07

1.5

1.7

91.00

90.69

umol/l

0.02

312

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.76

1.06

1.5

2.2

2.07

2.57

ratio

0.41

(3048929) Epstein Barr virus Ab [Presence] in Serum

804

1.21

1.05

1.1

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

574

6157

0.92

1.04

4.9

5.5

32.79

32.96

0.13

350

4051

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

2.27

1.03

1.0

—

38.52

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

2.27

1.03

1.4

1.1

14.42

24.23

nmol/l

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

2.27

1.03

1.0

—

21.25

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.27

1.03

3.2

2.5

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.83

1.02

1.3

1.6

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

179

1.45

1.02

1.1

1.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

205

1813

1.14

1.01

3.0

1.6

35.43

35.60

mg/l

0.02

175

1516

(40758292) HTLV I+II Ab panel - Serum

2.00

1.00

1.3

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

231

1.39

0.99

1.5

1.3

43.17

34.17

u/l

0.55

158

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

3621

35594

1.05

0.98

43.8

21.0

329.65

332.29

g/l

56.45

3598

35386

(3006922) Hepatitis E virus Ab [Presence] in Serum

274

1.35

0.98

1.0

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

131

0.53

0.98

1.1

1.5

9.98

9.84

ug/l

—

131

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.80

0.98

2.1

2.7

0.82

0.48

u/field

0.40

(3023323) Follitropin [Units/volume] in Serum or Plasma

721

1.21

0.96

1.3

37.25

31.38

iu/l

0.83

622

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

132

1.52

0.96

1.7

1.4

13.67

18.15

pmol/l

1.93

104

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.00

0.96

0.0

1.1

—

0.02

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

1.74

0.96

1.2

6.74

1.07

mmol/l

—

(3002523) Influenza virus A Ag [Presence] in Specimen

460

1.26

0.96

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.95

0.0

1.4

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

568

0.77

0.94

1.1

6.48

23.09

au/ml

—

(3020650) Glucose [Presence] in Urine

133

1.51

0.94

1.3

1.7

0.00

0.09

estimate

1.35

133

(3034860) Kappa light chains.free [Mass/volume] in Serum

204

1815

1.13

0.93

3.0

1.6

60.02

48.05

mg/l

1.08

175

1524

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.22

0.93

2.7

1.9

—

(21494890) Protein electrophoresis panel - 24 hour Urine

480

1.25

0.93

2.2

1.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

522

0.76

0.93

1.1

—

(3014891) Appearance of Pleural fluid

1.72

0.92

2.1

1.5

—

(3014271) Vancomycin [Susceptibility]

295

1.32

0.92

2.8

3.0

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

2.14

0.91

1.0

1.3

855.33

333.96

u/l

—

(3036670) Protein [Mass/volume] in Synovial fluid

195

0.61

0.90

1.2

41.63

40.04

g/l

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

102

0.49

0.89

3.0

3.1

7.21

7.14

mg/l

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

218

0.64

0.88

1.3

1.1

—

(3000285) Sodium [Moles/volume] in Blood

130

0.54

0.87

1.1

1.3

136.86

138.68

mmol/l

—

109

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

263

1.33

0.87

1.3

1.2

—

(3003181) Sodium [Moles/volume] in Urine

114

982

1.16

0.85

1.5

1.4

61.57

61.17

mmol/l

0.03

789

(3039443) Prostate specific Ag panel - Serum or Plasma

928

0.84

0.82

1.4

1.6

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.88

0.81

1.3

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

644

1.20

0.81

1.5

—

(3016228) CD19 cells/cells in Blood

1.57

0.81

1.4

2.1

7.21

8.10

0.17

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.70

0.80

1.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

397

0.75

0.80

1.0

1.1

—

(3016879) Cocaine [Presence] in Urine

531

0.79

1.1

1.9

—

(3028026) IgM [Mass/volume] in Serum or Plasma

258

2353

1.10

0.79

2.1

1.5

1.57

1.16

g/l

1.37

240

2150

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.82

0.79

1.7

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.82

0.79

1.7

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.82

0.79

1.7

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.77

0.0

1.4

—

(3010838) Calcium [Moles/time] in 24 hour Urine

770

0.83

0.77

1.6

2.0

4.76

4.85

mmol/24h

0.07

666

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.00

0.76

0.0

9.8

—

170.61

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

261

1.30

0.76

1.3

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

171

1906

0.89

0.75

1.2

1.3

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.70

0.75

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

392

3653

1.08

0.75

2.0

2.3

11.62

15.15

nmol/l

12.36

337

3282

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

297

1.28

0.75

1.0

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

743

1.17

0.74

1.4

15.18

8.52

u/l

2.69

588

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.57

0.74

1.0

1.2

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

315

1.27

0.74

1.2

1.6

—

(3004451) EKG impression Narrative

333

1.26

0.74

1.2

1.3

—

(3046861) Legionella sp Ag [Presence] in Urine

2.00

0.72

1.0

—

(4133840) Spirometry

100

1.50

0.72

1.3

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

112

1278

0.87

0.72

1.5

1.7

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.67

0.72

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

246

1.30

0.71

1.1

1.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

170

1888

0.90

0.71

1.7

1.8

39.72

38.82

u/l

0.21

153

1611

(3016650) Hepatitis A virus Ab [Presence] in Serum

581

1.19

0.70

1.0

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

433

0.78

0.70

1.2

1.8

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1270

12279

1.04

0.69

3.2

3.0

0.80

0.73

ug/l

1.17

885

8404

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.51

0.69

1.4

1.1

—

(3025130) Human papilloma virus identified in Specimen

310

1.26

0.69

1.6

1.9

—

(4146454) Self-monitoring of blood glucose

648

1.18

0.68

3.1

2.7

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.53

0.68

1.2

1.1

—

(4024509) Urine culture

263

2424

1.09

0.67

2.2

2.0

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.63

0.66

1.1

1.2

—

0.08

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

0.53

0.66

1.2

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

1.51

0.66

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

180

1.33

0.64

1.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

180

1.33

0.64

1.8

1.3

29.21

8.96

umol/l

0.53

117

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1041

0.87

0.63

1.2

5.51

5.17

u/ml

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

481

0.81

0.63

1.1

1.3

—

(3002079) Sodium [Moles/time] in 24 hour Urine

212

0.71

0.63

1.3

1.2

166.87

176.72

mmol/24h

0.10

212

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

562

1.18

0.62

1.2

1.5

164.28

152.59

au/ml

0.45

186

(40760888) Immunoglobulin light chains.free panel - Serum

131

1172

1.12

0.62

2.3

1.5

—

1.29

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

130

1.39

0.61

1.2

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

467

0.81

0.60

1.1

6.67

3.38

u/ml

0.53

223

(3008401) Mugwort IgE Ab [Units/volume] in Serum

456

0.81

0.60

1.1

1.77

1.12

u/ml

0.38

186

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

101

1142

0.88

0.60

1.8

1.9

11.21

12.02

mg/l

0.53

1060

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

200

1.30

0.60

1.2

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

345

0.78

0.60

1.1

1.2

2.63

2.26

mmol/l

0.63

325

(3024980) IgG subclass 4 [Mass/volume] in Serum

737

0.85

0.60

1.4

1.6

0.89

0.87

g/l

0.02

572

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.00

0.60

0.0

1.2

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.60

0.0

1.0

—

10916.33

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.60

0.0

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

198

0.71

0.60

1.1

0.95

1.12

u/l

—

(4062490) Immunoglobulin typing, IgG

455

0.81

0.59

1.4

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

174

0.69

0.59

1.1

1.4

42.98

57.29

0.64

153

(3052592) Norovirus Ag [Presence] in Stool

1.44

0.58

1.6

1.4

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

254

0.75

0.58

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

573

0.84

0.58

1.1

3.74

1.36

u/ml

0.51

316

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

422

4461

0.94

0.58

1.6

1.8

1.60

1.56

0.43

356

3796

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

1.71

0.57

1.0

1.2

—

15.71

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

116

0.60

0.57

1.3

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.45

0.56

1.0

1.1

—

(3025577) Chromium [Mass/volume] in Blood

385

0.80

0.55

2.4

2.1

2.37

2.24

ug/l

0.09

317

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

634

1.15

0.55

2.0

2.3

53.98

24.56

mg/l

1.96

221

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

318

0.79

0.55

1.2

1.1

—

(3028433) Virus identified in Specimen by Culture

123

0.65

0.54

1.4

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.48

0.53

1.8

1.3

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

160

1.31

0.53

1.1

1.2

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

432

1.18

0.53

1.2

98.36

95.90

0.26

406

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.54

0.53

1.2

1.1

7.83

9.82

u/l

—

(3006653) Thiamine [Moles/volume] in Blood

238

0.76

0.53

1.1

1.2

127.47

136.14

nmol/l

0.43

238

(4027681) Cerebrospinal fluid IgG ratio and IgG index

204

0.73

0.52

1.4

1.2

0.64

0.50

ratio

—

127

(3034426) Prothrombin time (PT)

133

0.68

0.51

1.1

1.2

26.78

28.72

—

133

(3020191) Ethanol [Moles/volume] in Serum or Plasma

380

0.81

0.51

1.2

1.3

0.85

1.11

promille

0.49

293

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

292

0.79

0.51

1.1

0.28

0.36

u/ml

—

(3027008) Opiates [Presence] in Urine

564

0.85

0.51

1.1

1.9

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

357

0.81

0.49

1.1

2.80

2.27

u/ml

0.14

170

(3044941) Cell count panel - Synovial fluid

998

0.89

0.49

1.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

156

0.70

0.49

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

389

0.82

0.49

1.1

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

144

0.69

0.49

1.2

1.4

—

(3011288) Drugs identified in Urine by Screen method Nominal

367

0.82

0.49

1.0

2.7

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

356

0.81

0.48

1.2

1.1

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

178

0.73

0.48

1.9

82.06

54.22

ug/l

0.82

173

(3023430) Cat dander IgE Ab [Units/volume] in Serum

333

0.81

0.47

1.1

2.18

3.99

u/ml

0.68

135

(3018333) Ribosomal P Ab [Presence] in Serum

311

0.80

0.47

1.2

1.1

—

(3028300) Cannabinoids [Presence] in Urine

568

0.86

0.45

1.1

1.9

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1022

0.90

0.45

1.8

6.00

9.87

iu/l

0.26

380

(3013139) Helicobacter pylori Ag [Presence] in Stool

292

3090

0.94

0.45

1.2

1.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

228

1.23

0.45

2.2

2.0

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2137

21015

1.03

0.44

2.3

2.4

75.50

78.75

nmol/l

5.54

1887

18553

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.37

0.44

1.3

1.7

—

(3011985) Renin [Units/volume] in Plasma

696

1.12

0.43

1.3

1.4

49.55

70.49

mu/l

0.88

630

(3023410) Appearance of Cerebral spinal fluid

415

0.84

0.43

1.3

1.4

—

(3024932) HLA-DR beta [Type]

0.64

0.42

1.5

1.0

—

(4198724) Urine methamphetamine measurement

0.64

0.42

1.7

1.6

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.64

0.42

1.3

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

240

2259

1.07

0.42

3.4

3.1

4.38

4.43

pmol/l

0.31

217

1992

(3000764) Benzodiazepines [Presence] in Urine

563

0.87

0.41

1.1

1.9

—

(3006270) Folate [Moles/volume] in Blood

445

0.85

0.41

1.3

1.2

354.67

346.17

nmol/l

0.08

351

(3033942) Copper [Moles/time] in 24 hour Urine

0.00

0.41

0.0

1.1

—

0.21

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.41

0.0

1.1

—

29.83

—

(3042517) Benzodiazepines panel - Urine

0.00

0.41

0.0

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

652

1.12

0.41

1.3

308.93

291.16

pmol/l

0.12

542

(3021788) Differential panel - Synovial fluid

1035

0.91

0.40

1.4

1.5

—

1.00

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

0.19

—

(3027944) Amphetamines [Presence] in Urine

561

0.87

0.40

1.1

1.8

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

205

0.78

0.40

1.1

1.2

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

465

0.86

0.40

1.4

0.33

0.41

g/l

1.08

339

(3028192) IgG subclass 2 [Mass/volume] in Serum

465

0.86

0.40

1.4

2.41

2.99

g/l

1.67

336

(3027135) IgG subclass 1 [Mass/volume] in Serum

465

0.86

0.40

1.4

6.02

6.88

g/l

0.91

336

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

5.56

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

0.00

0.40

0.0

1.9

—

1.89

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.40

0.0

1.1

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

0.16

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

570

0.88

0.39

1.3

1.36

1.46

nmol/l

0.28

510

(3006462) Nitrate [Presence] in Urine

205

1.22

0.39

4.0

3.2

—

(44806420) Estimation of glomerular filtration rate

409

0.85

0.38

2.9

2.6

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

581

1.12

0.37

1.2

3.61

2.97

u/ml

0.15

191

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

112

0.71

0.37

1.0

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

572

1.12

0.36

1.2

1.3

233.37

273.15

u/ml

0.55

355

(40759836) Histone Ab [Presence] in Serum by Immunoblot

343

0.84

0.36

1.2

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

343

0.84

0.36

1.7

1.9

91.22

109.81

ng/l

0.96

343

(3004588) Protein electrophoresis panel - Serum or Plasma

382

3662

1.05

0.36

2.5

1.5

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

220

2078

1.06

0.36

2.8

1.4

2.94

2.90

g/l

0.32

196

1841

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

233

2207

1.06

0.35

2.7

1.4

4.15

4.21

g/l

0.60

209

1973

(44813793) Dust mix specific IgE antibody measurement

277

0.83

0.35

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

480

0.87

0.35

1.1

1.3

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

123

0.73

0.35

1.0

1.1

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1035

0.92

0.35

1.2

1.3

216.67

440.48

titre

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

178

1673

1.07

0.35

2.0

2.9

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

795

1.10

0.34

1.2

95.18

19.04

u/l

1.07

680

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

233

2211

1.06

0.34

2.7

1.4

7.35

7.48

g/l

0.69

208

1973

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

340

0.85

0.34

1.1

1.2

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

232

2202

1.06

0.33

2.7

1.4

3.72

3.78

g/l

0.28

207

1965

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1001

0.92

0.33

1.3

1.5

1.06

0.85

nmol/l

1.03

830

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

491

1.12

0.33

1.1

1.0

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

403

0.87

0.33

1.1

3.31

1.27

u/ml

0.49

195

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

339

0.85

0.33

1.1

1.2

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1004

9820

1.03

0.32

1.7

1.8

1119.04

1144.97

nmol/l

0.38

757

7463

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1693

17188

0.98

0.32

4.3

4.1

20.65

24.53

22.38

866

8546

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.28

0.32

1.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

1060

0.92

0.32

3.7

27.69

28.35

mg/l

0.07

760

(3022621) pH of Urine by Test strip

393

3786

1.04

0.31

2.9

2.7

6.05

6.03

0.21

304

2666

(3050129) First trimester maternal screen panel - Serum or Plasma

1.30

0.31

1.4

1.3

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

174

1.21

0.31

1.6

1.8

0.48

0.68

e9/l

1.90

163

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

505

5209

0.97

0.30

2.0

2.5

6.68

7.94

ug/l

0.77

434

4574

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

561

1.11

0.30

1.1

1.2

0.19

0.20

nmol/l

0.08

468

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

571

1.10

0.30

1.2

3.09

5.11

u/ml

1.26

263

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

325

0.86

0.30

1.2

1.59

1.03

u/ml

0.16

194

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

120

1.25

0.30

1.1

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

185

0.81

0.29

1.1

1.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

639

1.10

0.29

1.2

1.5

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

306

1.14

0.29

1.2

1.5

14.92

14.35

umol/l

0.14

280

(3028679) Herpes simplex virus Ab [Presence] in Serum

163

0.80

0.29

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.25

0.29

2.0

1.6

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

297

1.15

0.29

2.5

2.4

—

(40768797) Stomach Pathology biopsy report

657

6401

1.03

0.29

1.3

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

733

0.91

0.29

1.3

1.5

—

(4211845) Urine protein measurement

232

1.16

0.28

3.9

3.0

—

(3023419) Bacteria identified in Sputum by Culture

700

0.91

0.28

2.0

2.5

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

122

1298

0.94

0.27

1.6

1.5

0.24

g/l

0.56

114

1237

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

331

0.88

0.26

1.1

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

141

1.21

0.26

1.4

1.5

1312.99

941.74

mu/l

0.47

110

(4195642) Thrombophilia screening test

539

1.10

0.26

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

244

1.15

0.25

1.5

1.4

0.47

0.24

nmol/l

0.52

184

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

207

1.16

0.25

1.8

1.1

40.44

39.57

g/l

0.37

207

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

608

1.09

0.24

1.1

1.2

—

43.22

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

722

0.93

0.22

1.6

1.9

240.83

289.86

mu/l

1.54

667

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1.25

0.22

1.3

1.4

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.19

0.21

1.6

1.4

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.04

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.0

—

2.11

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

127

1335

0.95

0.21

1.6

1.5

1.16

1.19

g/l

0.51

120

1269

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

4.8

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.4

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

0.10

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.24

0.20

1.0

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1.24

0.20

1.3

1.4

1.07

0.95

ratio

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

1.24

0.20

1.3

1.2

2.03

1.33

mmol/l

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1.24

0.20

1.3

1.4

1.15

1.17

ratio

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1.24

0.20

1.3

1.4

0.98

1.20

ratio

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

198

0.86

0.20

2.2

2.4

63.23

55.86

umol/l

0.41

172

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

152

1454

1.05

0.20

3.1

1.5

0.00

g/l

-0.00

140

1346

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

878

1.06

0.20

1.5

1.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1137

11214

1.02

0.20

1.7

1.8

20279428.74

29174336.27

pmol/l

0.25

932

9200

(21491868) Cryoglobulin [Mass/volume] in Serum

144

0.83

0.19

1.2

—

0.09

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

199

1919

1.04

0.19

2.7

1.4

10.43

10.14

g/l

0.41

173

1663

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.21

0.18

1.0

1.2

—

(40757373) Influenza virus identified in Isolate

1.21

0.17

1.4

1.5

—

(3004775) Volume in Urine collected for unspecified duration

443

0.92

0.16

2.1

2.3

658.92

631.52

0.27

297

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

662

1.06

0.15

1.2

1.3

0.10

0.36

nmol/l

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

297

0.91

0.15

1.0

1.1

0.89

10.17

nmol/l

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

165

1595

1.04

0.15

3.2

1.5

0.01

g/l

0.05

149

1439

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

161

0.87

0.15

1.0

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1.12

0.15

1.3

1.5

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

327

0.92

0.14

1.6

1.2

106.90

101.63

pmol/l

0.28

327

(3010503) CD19 cells [#/volume] in Blood

150

1.13

0.14

1.4

1.9

77.94

138.63

e6/l

1.56

142

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

179

1.12

0.14

1.2

1.1

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

1.19

0.14

1.2

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

232

0.90

0.13

1.0

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

167

1621

1.03

0.13

1.6

22.91

23.66

u/ml

0.06

300

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

209

1.10

0.13

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

579

1.05

0.13

1.3

1.4

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

540

1.06

0.12

1.1

1.2

110.58

114.30

0.49

485

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

365

0.93

0.12

1.2

74.00

171.88

titre

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

692

0.95

0.12

1.1

129.07

650.54

iu/ml

0.68

126

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1.18

0.12

1.4

1.6

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

551

1.05

0.12

1.1

1.3

—

nmol/l

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

193

1882

1.03

0.12

3.0

1.5

0.85

0.38

g/l

1.45

169

1614

(3000034) Microalbumin [Mass/volume] in Urine

504

0.95

0.10

3.5

3.0

40.48

33.77

mg/l

0.22

380

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

565

0.96

0.10

1.1

—

(3044927) Protein electrophoresis panel - Urine

585

0.96

0.09

1.1

1.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

377

3823

0.98

0.09

3.4

4.1

92.28

98.85

ng/l

0.73

317

3233

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

1.06

0.09

1.0

1.2

18.80

15.80

u/l

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.15

0.09

1.5

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.07

0.08

1.0

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1.07

0.08

1.5

1.6

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

449

1.05

0.08

1.1

1.4

—

(40768443) Skin Pathology biopsy report

192

1884

1.02

0.08

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

511

0.96

0.08

3.2

3.7

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.09

0.08

1.0

1.2

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

123

0.89

0.08

1.1

1.2

16.00

10.57

pmol/l

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

157

1538

1.02

0.08

3.1

1.4

0.00

g/l

-0.00

141

1350

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

0.82

0.07

15.7

13.0

5.23

4.95

mmol/l

—

(40768446) Kidney Pathology biopsy report

176

1.08

0.07

1.4

1.7

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

641

0.97

0.07

1.1

1.2

192.68

196.67

miu/ml

0.02

233

(3023511) Choriogonadotropin [Units/volume] in Urine

112

0.89

0.07

1.5

1.2

—

(3008295) Osmolality of Serum or Plasma

491

1.04

0.07

1.3

1.4

273.24

276.11

mosm/kgh2o

0.56

369

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

255

0.94

0.07

2.9

4.6

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

122

0.90

0.07

1.0

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.86

0.06

1.0

1.5

—

0.60

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.85

0.06

1.5

1.1

—

(3024471) HLA-A [Type]

0.84

0.06

1.0

—

(3032057) Clostridioides difficile [Presence] in Stool

100

0.90

0.06

2.3

1.7

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

102

0.88

0.06

2.3

2.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

102

0.88

0.06

2.3

2.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

133

1307

1.02

0.05

3.1

3.3

0.78

0.83

nmol/l

0.57

110

1080

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

474

1.03

0.05

1.6

1.7

36.00

26.05

u/ml

0.72

106

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

149

1.07

0.05

1.1

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

161

0.93

0.05

3.5

1.7

249.73

175.84

1.36

154

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

110

1.09

0.05

1.0

1.1

—

24.03

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

130

0.92

0.04

1.0

1.5

1315.98

76.69

nmol/24h

0.45

130

(3027923) C peptide [Moles/volume] in Serum or Plasma

299

1.04

0.03

1.4

1.3

1.08

1.22

nmol/l

0.41

216

(3016244) Insulin [Units/volume] in Serum or Plasma

151

1.06

0.03

2.3

3.0

22.76

20.87

mu/l

0.10

143

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

161

1.06

0.03

9.7

6.3

71.18

68.47

0.19

133

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

201

1.04

0.03

1.5

1.7

85.27

136.37

umol/l

1.00

101

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

397

3949

1.01

0.03

1.5

1.4

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

118

0.93

0.03

5.0

7.1

10.75

10.22

0.72

118

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

118

0.93

0.03

1.0

1.1

—

(37208534) Antinuclear antibody arbitrary concentration in serum

132

1.06

0.02

1.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

142

1.06

0.02

5.7

7.5

6.23

5.13

kpa

0.64

142

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

222

1.04

0.02

1.1

1.5

—

(3017704) Immunofixation for Urine

272

1.03

0.02

1.4

1.2

—

(3020491) Glucose [Moles/volume] in Blood

336

0.98

0.00

1.6

2.3

7.18

6.86

mmol/l

0.28

222

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

103

0.97

0.00

1.0

1.1

107.60

102.26

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

128

1.02

0.00

1.1

—

(3016750) Collection duration of Urine

303

0.99

0.00

2.1

2.0

496.38

498.84

min

0.04

227

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

116

1.03

0.00

3.9

2.5

0.78

0.90

ug/l

0.14

107

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

792

1.00

0.00

1.2

1.1

—

0.98

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

126

1.03

0.00

1.3

1.2

14.92

10.16

mm/h

0.40

126

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

122

0.98

0.00

1.3

1.5

1.15

1.17

mmol/l

0.41

122

(4268621) Lupus anticoagulant assay

407

1.01

0.00

2.3

—

(3033099) Centromere Ab [Titer] in Serum

1.03

0.00

1.0

1.2

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

202

0.99

0.00

1.2

1.3

6.13

6.22

mmol/l

0.15

191

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

155

0.97

0.00

1.1

1.3

—

1611885.57

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.94

0.00

1.2

1.6

56.40

45.57

umol/l

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

(3034614) HLA Ag [Interpretation]

0.00

-0.00

0.0

1.2

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.00

-0.00

2.5

1.8

14.70

18.78

umol/l

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.00

-0.00

1.1

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

(3014171) Thiocyanate [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

152.33

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

148.62

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

0.98

-0.00

9.6

4.6

71.00

42.54

ug/min

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

4100.00

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

-0.00

0.0

1.2

—

2.80

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.03

—

(3001556) Androgen free Index in Serum or Plasma

0.00

-0.00

0.0

1.3

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.3

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

-0.00

0.0

1.3

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.2

—

2.47

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

1273.33

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3007463) Buprenorphine [Presence] in Urine

0.00

-0.00

0.0

11.7

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

0.93

-0.00

1.2

1.5

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.4

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.9

—

2.07

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

7.0

—

0.19

—

(3005067) clonazePAM [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

49.56

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

377.60

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_RECTUM_WIDE – Malignant neoplasm of rectum, including Hilmo

GWS hits: 15

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of rectum, including Hilmo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Malignant neoplasm of rectum, including Hilmo (C3_RECTUM_WIDE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints